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Four different novel surface modification techniques have been investigated to enhance the cell 
growth behavior in metallic implantable materials. The potential of each technique has been 
studied for improving current treatments in a target disease. The first surface modification 
technique is the creation of nanoscale grain surfaces on stainless steel 316L material via linear 
plane-strain machining. The in vitro cell adhesion study demonstrates the enhanced osteoblast 
adhesion and growth on the native oxide layer formed on the material with the smallest grain size 
(i.e., created by 0° rake angle). This result represents a high potential of nanoscale grain surface 
in stainless steel for improving the bone bonding for orthopedic biomaterials. The second surface 
modification technique is a rapid endothelialization of thin film nitinol through electrostatic cell 
seeding process. This technique utilizes dielectrophoresis supplying for temporarily created 
positive surface charges on thin film nitinol. In vitro cell adhesion assays have demonstrated the 
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enhanced seeding of endothelial cells on thin film nitinol under the optimal electrical conditions 
(i.e., 5V applied voltage for 30 minutes) which shows the potential use of the technique for thin 
film nitinol based low-profile endovascular graft. In the third technique, a thin layer of silk is 
deposited on the thin film nitinol substrate using electrospinning technique to facilitate the 
surface endothelialization and to enhance the hemocompatibility. The proof-of-concept in vitro 
test results have demonstrated that the integrated thin film nitinol and electrospun silk represents 
a high-potential candidate material for small-diameter vascular grafts owning to favorable 
properties of thin film nitinol and silk. The last technique introduces the micropatterned thin film 
nitinol as a novel low-profile cover for stents in treating carotid artery stenosis disease. A sputter 
deposition technique along with a lift-off process was used to create various microscale features 
in thin film nitinol. The micropatterned thin film nitinol effectively captured the embolic 
particles dislodged from the carotid artery stenosis in vitro model. Besides, the micropatterned 
thin film nitinol has significantly enhanced endothelial cell adhesion and growth. Therefore, four 
surface modification techniques showed advancement in cellular behavior with the various 
metallic biomaterials used in treating critical diseases.   
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1.0  BACKGROUND 
Millions of people around the world are receiving implanted medical devices and biomaterials to 
replace the function of the diseased tissue. Despite the important role of implants in saving 
people’s life and improving the quality of their life, many of these implanted devices and 
biomaterials fail in a short term and have many complications. Major failure in biomaterials is 
from their inadequate biocompatibility. Biocompatibility is defined as follows: 
“The ability of a biomaterial to perform its desired function with respect to medical 
therapy, without eliciting any desirable local or systemic effects in the recipient or beneficiary of 
that therapy, but generating the most appropriate beneficial cellular or tissue response in that 
specific situation, and optimizing the clinically relevant performance of that therapy”(Williams, 
David F., Biomaterials, 2008). 
Based on this definition, biocompatibility testing consists of a wide variety of tests for 
evaluating the suitability of the biomaterials that contact with the human body both in a short and 
long term. Therefore, the evaluation of the biomaterials’ surface, mechanical and biological 
properties are primary categories of biocompatibility testing. Implantable medical devices and 
biomaterials must undergo numerous biocompatibility tests depending on the host location and 
type of the device to ensure their safety and effectiveness prior to be used in human body. In 
vitro cell culture tests are highly favorable and have been widely used to assess the important 
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biological response of the implanted biomaterials and to study the cellular interaction with them 
before entering clinical trials. Typical cell culture studies include cell adhesion, migration, 
proliferation and differentiation studies and any of these should be specifically chosen depending 
on the type of implantable devices and biomaterials.   
This dissertation includes four major sections. Disease backgrounds are first introduced 
and the limitations of current devices and biomaterials (e.g., biocompatibility) are discussed. 
Novel surface treatment strategies are suggested for each device or material to overcome the 
biological complications occurred in the current treatments. This dissertation brings up today’s 
significant challenges found in the biomaterials field related to cell-biomaterials interface. In 
addition, this study presents novel solutions and useful information to meet these challenges and 
shed some light on these complications.  
Two types of materials that are used for presenting these strategies include 316L stainless 
steel and thin film nitinol. 316L stainless steel has been widely used as a biomaterial in bone 
fixation devices (plates, screws and pins) and artificial joints. Thin film nitinol shows a high 
potential for new small vascular devices (e.g., heart valves and covering stent grafts) due to its 
unique and beneficial properties (e.g., superelasticity and low-profile feature).  
After indicating the challenging issues of current treatments in each disease and 
presenting the techniques to obviate these obstacles, in the next step, appropriate in vitro tests 
have been used to examine the effectiveness of the new techniques in resolving the implied 
challenges. In each case, the suggested technique is compared to the current treatment to 
demonstrate the level of effectiveness of the suggested technique.  
3 
In the first part, four groups of 316L stainless steel surfaces with average grain sizes in 
the range of 42nm (i.e., corresponding to 0°-tool-rake-angle-obtained chip) up to 22µm (i.e., 
corresponding to bulk sample) have been used. 
 The first generation of bone implants was filling the empty space of the lost tissue in the 
bone showing inert biological response. As an example, metallic biomaterials such as stainless 
steel substrates with passivated oxide layers on their surface demonstrate corrosion resistance 
and inert surfaces in the biological environment. However, one of the main failure reasons of 
orthopedic implanted materials is the weak connection between the surface of the implanted 
material and bone. Therefore, if the bonding between the bone and the surface of the implant 
improves, the performance and lifetime of it increases. Hence, in biomaterials field, one of the 
important research areas is to improve the biocompatibility by modifying the biomaterials 
surface. Biomaterials with modified surfaces can improve the host response in the direction to 
accept the biomaterial instead of ignoring it as inert biomaterials.  
Since interactions between cells and biomaterial surfaces are mediated by molecules and 
cell membrane at nanoscale dimensions, creating nano-structure surfaces for biomaterials can 
influence the cellular behavior in the interface of biomaterials and biological cells, for example, 
increasing the attachment of bone cells. Accordingly, the potential of ultrafine grain size 316L 
stainless steel substrates is examined for improving the bone bonding for orthopedic implants.  
The mechanism behind the enhancement of cell attachment on the ultrafine grain size 
substrates has not been explicitly known and there is the lack of understanding regarding to the 
effects of refining the grain size on cellular response. Since the cells directly contact with oxide 
layer formed on the surface, we characterize the properties of the oxide formed on the nanograin 
substrates. In addition to naturally formed oxide layer, by using thermal and chemical treatment 
4 
methods, oxide layer is grown on the nanograin substrates. Growing oxide layer on the surfaces 
with different average grain sizes facilitates the study of the effect of grain size refinement on the 
surface oxide properties; furthermore, growing oxide layer along with refining the grain size 
creates surfaces with various surface properties (e.g., surface roughness).  
In order to discover the surface that possibly enhances the bone attachment, MC3T3 
(precursor osteoblast cells) cells are cultured on the surfaces and the adhesion and proliferation 
of them are assessed on the all the oxide surfaces. The results demonstrate that the adhesion of 
osteoblasts attachment are higher on the surface of naturally oxide layer compared to thermally 
and chemically formed oxide layers and the adhesion of cells enhances on the surface with the 
smallest average grain size (i.e., obtained by 0° tool rake angle). Therefore, the naturally formed 
oxide layer on the surface of 316L stainless steel with nanoscale average grain size (i.e., ~ 42nm) 
demonstrate a high potential in enhancing the bone attachment and reducing the loosening 
occurrence in orthopedic biomaterials. To understand the reason behind enhancing osteoblast 
adhesion on the naturally formed oxide layer on 0° chips compared to all other surfaces, 
important surface properties which determine the cellular response (i.e., surface topography, 
chemistry and surface wettability) are analyzed. In future studies, the microstructure of oxide 
layers formed on the nanograin substrates will be fully analyzed using transmission electron 
microscopy (TEM) imaging to achieve a better understanding about the effect of grain size 
refinement on the cell adhesion.  
In addition to orthopedic biomaterials, the other high-demanding group of biomaterials is 
endovascular devices. Small-diameter vascular diseases are mostly life-threatening and if not 
treated in an effective manner, they can cause serious damages or even result in death. In this 
dissertation, two new thin film nitinol-based endovascular biomaterials have been suggested 
5 
which show improvement in terms of their surface interaction with surrounding biological 
environment. These biomaterials include: 1) electrostatic endothelial cell seeded thin film nitinol, 
2) integrated thin film nitinol/electrospun silk. Three major features which affect the
performance of endovascular devices include: 1) bulkiness, 2) surface endothelialization, 3) 
blood-compatibility. Bulk devices occupy more volume of the blood vessel duct and raise the 
probability of thrombosis occurrence because of the high probability of blood flow disturbance; 
this factor highly matters in small-diameter blood vessel. Thin film nitinol demonstrates a 
significantly low profile (i.e., 6µm) compared to commercially available grafts such as e-PTFE 
or Dacron materials (i.e., 100-200µm); furthermore, due to the superelasticity of thin film nitinol, 
it can provide sufficient radial force to prevent migration under blood flow of small-diameter 
blood vessels without need to use vascular stent backbones which result in a significant reduction 
in the bulkiness of the device. 
Adhesion and growth of endothelial cells play a key role in the success of small-diameter 
vascular devices since endothelial cells can potentially enhance the thrombosis resistance similar 
to the native blood vessel tissue. A new electrostatic endothelial cell seeding inside the small-
size catheter (e.g., 6Fr) has been introduced in order to performing the endothelial cell seeding 
right before the endovascular surgery. The results demonstrate applying 5V voltage with induced 
electrostatic charge of 0.68×10-6µC and induced electric field of 5.11V/mm-1 for 30min duration 
on the superhydrophilic thin film nitinol substrate significantly enhances the attachment of 
endothelial cells.  
Besides, electrospun silk demonstrates a remarkable enhancement on endothelial cell 
adhesion and reduction in blood coagulation compared to control materials during in vitro tests. 
Therefore, the proof-of-concept in vitro testing results suggest that electrostatic endolthelial 
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seeded thin film nitinol and integrated thin film nitinol/ electrospsun silk and be promising 
candidate materials for small-diameter vascular devices and can create a significant improvement 
in the treatment of small-diameter vascular diseases.  
In addition to unique characteristics of thin film nitinol such as superelasticity and being 
low-profile, various micropatterns can be created on its surface. The micropatterned thin film 
nitinol is suggested to be used as a covering membrane for stents since the stents can open the 
narrowed blood vessel but they cannot prevent the dislodgment and embolization of 
microparticles from the plaques while a covering membrane can trap the embolic particles. 
Diamond-shape micropatterned covered stent can prevent the emboli dislodgement up to 85% 
through 30min in vitro tests. Besides, endothelial cell adhesion, growth and elongation 
significantly enhance on the micropatterned thin film nitinol surface. According to the in vitro 
results indicating the high emboli protection and enhanced endothelial cell coverage, micro-
patterned thin film nitinol represents a high-potential low-profile candidate membrane for 
covering the vascular stent in treating carotid artery stenosis.  
Consequently, this dissertation presents primary in vitro results of enhancing the cell 
attachment on the surfaces of the metallic substrates (i.e., 316L stainless steel and thin film 
nitinol) which have been modified by using the surface modification techniques including 
refining the average grain size of 316L stainless steel substrate, inducing the electrostatic charge 
on thin film nitinol surface, coating the thin film nitinol surface with nanofibrous silk and 
creating micropatterned surfaces on thin film nitinol. This dissertation introduces new 
biomaterials in order to improve the current treatments of several critical diseases and also sheds 
some light on several subjects in the category of biomaterials-cells interface. 
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2.0  INTRODUCTION 
Millions of people in the US use implanted medical devices, annually. Medical implants are 
placed permanently or temporarily into the damaged body parts to replace or support the missing 
body function. In addition to replacing the damaged body parts, implants can be used for various 
applications such as delivering medication, monitoring body functions or supporting the repair of 
damaged tissues.  Therefore, a wide variety of implanted medical devices have been developed 
for many different parts of the body such as hip implants, vascular grafts, bone grafts, dental 
implants, orthopedics screws and plates, pacemakers, cardiovascular stents, heart valve 
replacements and drug delivery systems (Figure 1). Metals are the most widely used materials 
for load-bearing implants such as fracture fixation plates, artificial joints, maxillofacial implants 
and dental implants. In addition, they are used for vascular stents and cardiovascular devices. 
The most commonly metals in biomedical applications are stainless steels, cobalt-base alloys, 
commercially pure titanium, titanium alloys and nickel-titanium (i.e., nitinol) alloy.  
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Figure 1: Examples of implants and medical devices[1] 
In recent decades, the use of medical implants is remarkably growing, for example, in 
2004, the number of implanted drug-eluting stents alone exceeded two million[2]. With the 
increasing population of patients, aging population and lengthening the life expectancy, 
developing a new generation of advanced biomaterials with longer lifetime and improved 
properties is required. In the implantable device, the interaction of biomaterials surface with 
biological cells and surrounding tissues is one of the most critical factors affecting the success 
and lifetime of them. Lack of sufficient integration between the implanted biomaterial and the 
host tissue results in the failure of implants[3, 4]. Therefore, a more detailed understanding of 
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interactions occurring in implants interface with their surrounding biological environment is 
known as one of the today fundamental requirements in biomaterial research field whereas the 
vast majority of the biological principles controlling the interaction of cells with implants remain 
largely ambiguous. Here, the interaction of cells with the implanted material surface and 
effective surface parameters regarding to this process as well as surface modification techniques 
to improve the bio-functionality of the metallic implantable materials are reviewed.  
2.1 CELL-SURFACE INTERACTION IN BIOMEDICAL IMPLANTS 
The cell–material interaction is a complex interplay of a variety of biological processes which is 
strongly influenced by implant surface properties such as surface hydrophilicity, surface 
roughness, texture and morphology as well as surface chemistry and surface electrostatic 
charge[5, 6]. Immediately after placing the implant inside the body, a water layer forms on the 
surface and the chemistry and electrostatic charge of the surface determine the level of water 
molecules dissociation and their bonding strength as well as the incorporation of the surrounding 
ions on covering the surface. Subsequently, the proteins existing in the biological fluid attach on 
the implant surface via physical or chemical bonds. The chemical and physical characteristics of 
the surface determine which proteins adhere on the surface and also determine their orientation 
and spatial arrangement. Protein adhesion on the surface is a thermodynamic process based on 
electrostatic, hydrophobic or covalent interactions which is also affected by the size and 
concentration of proteins[7, 8]. The interactions of surface-bound proteins with cells are 
mediated via integrins. Integrin receptors are heterodimers composed of α and β subunits that 
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occur in distinct combinations which then bind to speciﬁc ligands. Different cells express various 
integrins which the type and level of this expression is affected by physicochemical properties of 
the surface. For instance, microrough surfaces increase the expression of the β1 integrin subunit, 
which is essential in osteoblastic differentiation[9]. Apart from integrins in the surface, focal 
adhesions consist of speciﬁc proteins such as talin, α-actinin and vinculin ﬁlaments that interact 
with the cytoskeleton on the cytoplasmic side of the cells. Through focal adhesions, cells react to 
extrinsic chemical and mechanical signals from the cell–cell contact or cell-extracellular matrix 
(ECM) components. Changes in microscale and nanoscale of their surrounding environment 
(e.g., implant surface) cause signal transduction and lead to change in cell behavior since cells 
communicate with their surrounding environment via electrical, chemical and mechanical 
signals.  
Here, the role of important surface factors especially in metallic biomaterials in 
determining the biological cell behaviors have been reviewed:  
2.1.1 Surface chemistry 
Biocompatibility of metal biomaterials is due to forming a chemically stable oxide layer on their 
surface which separates the highly reactive bulk material from the biological environment. For 
instance, stainless steel materials are resistant to a wide range of corrosive agents due to their 
high chromium content (>12 wt%), which allows the formation of a strongly adherent, self-
healing and corrosion resistant coating oxide of Cr2O3. The oxide layer interacts with proteins 
and cells upon implantation since surface chemistry effectively influences proteins adsorption 
and their conformation, and initial cell attachment. For example, Rapuano and McDonald 
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showed that negatively charged functional groups of surface oxide in Ti6Al4V alloy can 
modulate ﬁbronectin integrin receptor activity by altering the adsorbed proteins 
conformation[10].  
2.1.2 Surface roughness, morphology and texture 
Three-dimensional morphology of an implant is thought to be a major factor in determining cell 
response and implant performance. Surface microroughness affects osteoblast differentiation as 
well as the synthesis of proteins such as collagen type I, vitronectin and ﬁbronectin[11]. 
In addition, cells interact and respond to the surface nanotopography[12]. Conformational 
changes in focal adhesions and cytoskeletal conformation transfer information about the ECM 
topography to the nucleus as mechanical signals. In response to mechanical signals, cytoskeleton 
filaments reorient and subsequently a distortion occurs in the cell nucleus which may induce 
changes in gene transcription[13].  
Surface topography is known as an effective factor on determining signaling pathways 
through modulation of integrin clustering[14].  
2.1.3 Surface energy and wettability  
Surface free energy is a more important surface characteristic than surface roughness for cellular 
adhesion strength and proliferation. Various models have been suggested to explain the 
relationship between the wettability and surface roughness[15]. According to Wenzel’s model, 
wettability decreases by roughening smooth hydrophobic surfaces and increases by roughening 
12 
smooth hydrophilic surfaces. Osteoblast cell growth and proliferation generally increases with 
increasing surface roughness and hydrophilcity[16]. It is shown that cell attachment and 
spreading are significantly greater on hydrophilic surfaces than on hydrophobic surfaces.   
2.1.4 Surface electrostatic charge 
Surface electrostatic charge affects the electrical parameters of cells and produces signals to 
regulate cell behavior. For example, increasing surface charge density is shown that improves the 
cell adhesion and proliferation in several polymeric substrates[17]. Furthermore, cell 
differentiation and adhesion change on surfaces with positive ions and the negative ions as 
well[18]. For instance, osteoblast and fibroblast adhesion improve in hydroxyethylmethacrylate 
(HEMA) hydrogels with positive charges compared to negative or neutral charges[19]. Surface 
charge may regulate protein adsorption and through it control the cell adhesion. It has been 
postulated that negative charge may facilitate adsorption of proteins and promote cell adhesion 
and responses. 
2.1.5 An example study on evaluating cell-surface interaction in biomedical implants 
(improved osteoblast response to UV-irradiated PMMA/TiO2 nanocomposites with 
controllable wettability) 
Chun et al., evaluated osteoblast response of PMMA/TiO2 nanocomposite thin films that 
exhibited the controllable wettability with UV treatment. In this study, three samples of 
PMMA/TiO2 were fabricated with three different compositional volume ratios (i.e., 25/75, 50/50, 
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and 75/25) followed by UV treatment for 0hr, 4hrs, and 8hrs. Surface profiler and atomic force 
microscopy demonstrated the increased surface roughness after UV irradiation due to the partial 
elimination of PMMA on the surface (confirmed by Fourier transform infrared spectroscopy 
(FTIR).  All samples showed the increased hydrophilicity after UV irradiation. The films 
fabricated with the greater amount of TiO2 and treated with the longer UV irradiation time 
increased the hydrophilicity more. The partial elimination of PMMA on the surface after UV 
irradiation created a durable hydrophilic surface by (1) exposing higher amount of TiO2 on the 
surface, (2) increasing the hydroxyl groups on the TiO2 surface, and (3) producing a mesoporous 
structure that helps to hold the water molecules on the surface longer. While all UV-treated 
hydrophilic samples demonstrated the improvement of osteoblast cell adhesion, the PMMA/TiO2 
25/75 sample after 8hrs UV irradiation (i.e., the superhydrophilic surface) represented the best 
cellular response as compared to other samples (Figure 2)[9]. 
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Figure 2: A) Water contact angle and B) Fluorescent images of attached MC3T3 cells before and after 4hrs and 8hrs 
UV irradiation on 25/75 PMMA/TiO2 nanocomposites[9] 
2.2 SURFACE MODIFICATION TECHNIQUES IN METALLIC BIOMEDICAL 
IMPLANTS 
To functionalize the surface of metallic implants, different physical and chemical surface 
treatments have been studied. One surface treatment strategy is coating the surface of the implant 
with a bioactive ceramic (e.g., hydroxyapatite (HA) and bioactive glass). Surface treatment 
methods for this coating include electrophoretic deposition, plasma spraying, radio frequency 
sputtering, laser ablation and hot isostatic pressure[20-25]. None of these methods produce 
covalent links with the substrate and in long-term implantation they can delaminate, besides, 
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there are difficulties in controlling the final composition and structure of the coating. While 
chemical surface modification (e.g., thermochemical techniques, sol-gel coating or attachment of 
self-assembled monolayers) obtains or induces the deposition of a bioactive ceramics on metallic 
surfaces in vivo and creates a direct chemical link between the substrate and the coating [26-28]. 
Surface bio-activation can be achieved by functionalizing surfaces with different biomolecules 
and biopolymers such as immobilization of ECM proteins, peptide sequences and DNA by 
applying a variety of methods where both chemical bonding and physical adsorption take place. 
With the advancements of technology, role of nanostructure surface of materials on improving 
cell behavior have been evaluating.  
2.2.1 Nano-functionalizing of metallic biomaterials 
Nanostructure surfaces have the ability to mimic the biological environment hereby improving 
the cell behavior and functionalizing the surface to bind to specific biological targets (e.g., 
ligands, proteins, antigens or cell types). For example, Webster et al., demonstrated increased 
osteoblast cell adhesion on different nanophase metallic microparticles (i.e., Ti, Ti6Al4V and 
CoCrMo) compared to conventional particles owning to creating surfaces with nanoscale 
roughness and increasing grain boundaries[29]. Multiple methods have been suggested to 
produce nanostructure metallic surfaces such as chemical etching, powder metallurgy techniques, 
anodic oxidation and nanocoatings[30, 31]. However, these methods require multi-step 
processes, they are chemically complicated, or result in uncontrolled surface property changes. 
Severe plastic deformation (SPD) techniques eliminate the concerns of conventional methods. 
SPD can result in extreme grain refinement obtaining nanograin material through large 
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deformations applied at high strain rates and relatively low temperatures. SPD methods can 
produce material with relatively higher strength and novel mechanical properties. These methods 
have high potential to produce a new generation of implant materials through concurrent 
enhancement of mechanical characteristics and biocompatibility[32].  
2.2.2  Thin film nitinol (TFN) biomaterial and surface modification techniques for it 
Nitinol, the acronym for Nickel Titanium Naval Ordinance, is an equiatomic nickel–titanium 
composition alloy that is known mostly for two unique properties of shape memory and 
superelasticity[33]. The shape memory response of nitinol is defined as the recovery of the 
material’s mechanical deformation when it is heated to above the transformation temperature 
(i.e., austenite phase) from a low temperature state (i.e., martensite phase). Another unique 
feature of nitinol is the superelasticity that provides high resistance against plastic deformation. 
Bulk nitinol has a long-track record of successful uses in many endovascular applications; 
however, nitinol-based devices are relatively bulky when used with synthetic graft materials such 
as expanded polytetrafluoroethylene (e-PTFE) or Dacron© polyester. In general, these devices 
could be used for treating vascular diseases in large diameter blood vessels such as abdominal 
aortic aneurysms; however, it is difficult to deliver the synthetic polymer-covered nitinol devices 
in many trauma situations. For example, it is challenging to deliver the device into the calcified 
blood vessels (i.e., narrowed vasculature), the highly tortuous small vascular systems, and 
pediatric patient’s blood vessels. Therefore, there is a significant need for the development of 
new biomaterials that are low-profile and hemocompatible, as well as deliverable to the desired 
disease locations with appropriate material properties such as elasticity, toughness, and fatigue 
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resistance. One novel material worth considering for developing a low-profile transcatheter 
device is the relatively new material, “thin film nitinol”[34]. Vacuum sputter deposition process 
for thin film nitinol is considered the preferred fabrication method, because of the precise 
controllability of the deposition process and the consistency of the quality of the films[35]. The 
thickness of thin film nitinol as materials in medical devices would be 3-12μm depending on the 
type of applications. Thin film nitinol can be used in small caliber vascular system, including 
cerebral, carotid, coronary, renal arteries and veins, and so on. In addition, thin film nitinol 
exhibits superelastic property in human’s body temperature, which improves the device 
apposition with vascular wall compared to any synthetic fabric that typically has wrinkles or 
permanent deformation. Vascular wall apposition is especially critical for the devices used in 
small and low blood flow vascular systems; therefore, thin film nitinol is a great candidate as a 
covering membrane for minimizing or preventing blood flow disruption and local thrombosis 
accumulation between the graft and vascular wall.  
While nitinol is a well-known biocompatible material, the thrombotic complications 
frequently occur when it is used for vascular implants in small arteries. A variety of factors 
including surface roughness, wettability, and surface charge, involve in thrombosis. It is known 
that native blood vessels are negatively charged and hydrophilic which has been postulated to 
decrease the attachment of blood products. Therefore, Chun et al., suggested different techniques 
to treat thin film nitinol surface in order to obtain a more hydrophilic and negatively charged 
surface (i.e., UV irradiation, heat treatment and H2O2 chemical modification)[36].  
UV irradiation induces a photochemical reaction on the surface including a reduction 
reaction of titanium ions in the surface oxide layer and the generation of vacancies in its oxygen. 
The oxygen vacancies cause surrounding water molecules to dissociate and the hydroxyl groups 
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absorb on the surface boosting the hydrophilicity and negative charge. However, UV irradiation 
didn’t significantly improve the wettability of nitinol thin film due to the extremely low 
thickness of the native oxide layer (less than 10nm) and the lack of the stability of absorbed 
hydroxyl groups on the surface. Another method to grow oxide layer was heat treatment, heating 
the sample above 600ºC resulted in the formation of a thick and uniform oxide layer (i.e., 
~100nm) on the surface creating a superhydrophilic surface but the thick surface TiO2 causes 
embrittlement in the film deteriorating the proper mechanical behavior. While both UV 
irradiation and heat treatment did not show the best results for creating a high-quality 
superhydrophilic surface, chemical modification using 30% H2O2 for 15hrs at room temperature, 
demonstrated that a high-quality hydrophilic surface was produced maintaining the desirable 
mechanical properties of the thin film[36].  
The ultra-smooth surface of thin film nitinol and the uniform oxide layer created by 
chemical treatment on its surface, obtains a superhydrophilic surface while the improvement of 
surface wettability in bulk nitinol after the similar surface treatment, is much less. Thus, this 
method is suggested the preferred surface treatment method to improve the biocompatibility of 
thin film nitinol[36]. 
In this dissertation, four different new techniques for improving the cell adhesion and 
growth in metallic biomaterials have been evaluated. For each technique, a disease has been 
targeted that the surface modification technique shows potential for improving the treatment for 
the disease. The first technique “obtaining nanograin surfaces by linear plane-strain machining” 
has been evaluated for stainless steel substrates for improving the osseointegration in orthopedic 
biomaterials applications. The other three methods are used for thin film nitinol  
substrates for vascular graft application.  
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3.0  TECHNIQUE 1: OBTAINING NANOGRAIN 316L STAINLESS STEEL BY 
LINEAR PLANE-STRAIN MACHINING 
3.1 INTRODUCTION 
Population aging and high incidence of osteoporosis, obesity and arthrosis all lead to increasing 
demands for orthopedic devices such that it is estimated that the number of total hip and knee 
joint replacements will be duplicated by the year 2015 and 2026, respectively[37]. Besides, it is 
estimated that from 2012 to 2019, the orthopedic devices market will grow from $29.2 billion to 
$41.2 billion[38]. In addition to increasing the demands, due to increasing the average life 
expectancy, development of novel orthopedic devices with higher durability and functionality are 
urgently required. Mechanical strength and stability is a fundamental requirement for orthopedic 
biomaterials since they are mostly used in load-bearing positions such as internal fixation 
devices and joint implants. Therefore, metals (i.e., titanium alloys, cobalt alloys and stainless 
steel) are the main composition used in orthopedic biomaterials providing sufficient strength 
under high static and cyclic loads[39, 40]. Although metals present a wide range of favorable 
mechanical properties for load-bearing orthopedic applications compared to ceramic and 
polymer compositions; however, they are all inert and do not interact with the biological 
environment to bond with the bone and enhance biological interface[41]. Therefore, improving 
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the biological function of metallic surface can open the window to design and develop novel 
durable orthopedic biomaterials. Biological cells do not directly attach to the biomaterial surface, 
they attach to proteins and biomolecules initially adsorbed on the surface and composition and 
configuration of these adsorbed proteins and biomolecules conduct signals to cells determining 
their behavior (e.g., adhesion, differentiation, proliferation and apoptosis). Since surface cell 
receptors and native ECM proteins are structured in nanoscale (e.g., 25-50 nm hydroxyapatite 
crystals and 300nm collagen fibrils in bone), it is indicated that cell signaling in biomaterial-
biological environment interface occurs in the nanoscale. Thus, engineering the surface in 
nanoscale has been inferred as an attractive technique to manipulate surface chemistry, 
roughness, topography and surface energy in nanometer scale  in order to control the absorbance 
of proteins and biomolecules in this scale and improving the cell behavior[6, 42, 43]. For 
example,  Webster et al., demonstrated increased osteoblast adhesion on different nanophase 
metallic microparticles (i.e., Ti, Ti6Al4V and CoCrMo) compared to conventional particles 
owning to creating surfaces with nanoscale roughness and increasing grain boundaries[29].  
Severe plastic deformation (SPD), is an alternative approach which can produce metals with 
ultra-fine grain sizes through applying large deformation at high strain rates [44, 45]. Under SPD 
processes, lattice defects within polycrystalline metals are annihilated and recombined creating 
new grain boundaries and refining the average grain size [46, 47]. SPD techniques do not have 
complications of other nanofabrication methods and also increase the mechanical strength of the 
bulk material. Multiple studies have investigated the effect of refining the grain size on the 
cellular behavior. In these studies, different SPD techniques such as equal channel angular 
pressing (ECAP), high pressure torsion (HPT) and severe cold rolling have been applied (Figure 
3) on a wide range of substrates (e.g., commercial pure titanium, Ti6Al4V alloy, pure iron, 
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nitinol alloy, copper, zirconium, stainless steel sample) using various types of cells (e.g., 
fibroblast cell, osteoblast cells and endothelial cells).  
 
 
 
 
 
 
Figure 3: Schematic illustration of examples of SPD techniques: (A) Equal channel angular pressing (ECAP), (B) 
High pressure torsion (HPT) and (C) Severe cold rolling[48] 
 
 
 
Table 1 reviews a number of studies about the effect of grain size refinement on the 
cellular behavior. Most of these studies report positive cellular responses (e.g., improvement in 
adhesion, proliferation, viability of cells) in ultra-fine grain size samples but there are also 
reports such as Saldana et al. study that observed no difference between the viability, 
proliferation and spreading of cells on the coarse grain and ultra-fine grain size Zirconium 
samples[49]. The reason behind the effect of grain size refinement on the cellular response is 
hypothesized the increase in the surface energy or creation of numerous nanoscale points to 
facilitate the attachment of cells[32]. 
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Table 1: Examples of studies about the effect of grain size refinement on the cellular behavior [49-56] 
 
 
 Substrate SPD 
Method 
Average 
Grain size 
Cell type Results 
1 Copper ECAP 260nm L929 Higher cell viability on NG 
samples ( MTT assay) 
2 Zirconium Severe 
rolling 
240nm SaoS-2 -Enhancement of Wettability in 
NG samples 
-No difference was observed 
between viability, proliferation 
and spreading of cells between 
samples 
3 Pure Ti ECAP 350-
450nm 
3T3 -Enhancement of wettability in 
nanograined (NG) samples 
- Higher Cell adhesion and 
proliferation on NG samples 
(MTT assay) 
-Higher adsorption of fibronectin 
protein on NG samples 
4 Pure Ti ECAP 200nm MC3T3-
E1 
-Higher Cell proliferation on NG 
samples 
(MTT assay) 
5 Pure Ti ECAP 170-
200nm 
hMSC -Different surface topography 
between control and NG samples 
(by AFM) 
-Higher cell adhesion and 
spreading on NG samples 
6 Pure Ti Surface 
mechanical 
attrition 
treatment 
(SMAT) 
 SaOs-2 -Higher Cell viability on NG 
samples 
7 Pure Ti HPT 10-50nm MC3T3 -XPS and XRD demonstrated a 
different oxide layer on the NG 
surface compared to control. 
- Wettability changes on NG 
samples 
-Higher cell adhesion on NG 
samples 
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Table 1 (continued) 
 
 
8 Nitinol HPT 200-
300nm 
L929 
Mg63 
-No difference for L929 but 
improvement in cell viability for 
MG63 cells on NG samples 
9 AZ31 Mg 
alloy 
Grove 
pressing 
(GP) 
5µm L6 -No difference in Viability (MTT 
assay) 
NG surfaces showing: 
- Higher surface wettability 
-Lower corrosion rate 
-Higher Bioactivity 
-Roughness increasing 
 
 
 
Linear plane-strain machining is a SPD method whereby a sharp tool quickly removes the 
surface metal in a predetermined depth and angle. In this method, grain size can be controlled by 
three parameters of rake angle, tool velocity, and cutting depth [57, 58]. Controlling the average 
grain size in nanoscale provides nanofunctional surfaces that can have potential applications to 
develop advanced biomedical implants and improve their performance. 
In this study, austenitic 316L stainless steel samples in three different nanoscale average 
grain sizes are obtained by linear plane-strain machining SPD technique. The aim is to 
investigate whether grain refinement by linear plane-strain machining technique in stainless steel 
316L can affect MC3T3 responses. To understand the effect of grain size refinement on surface 
characteristics and surface oxide structure, a comprehensive surface characterization is 
performed.  
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3.2 METHODS 
3.2.1 Preparation of test samples 
Commercially available, annealed and cold-finished 316L stainless steel plate (McMASTER-
CARR, Cleveland, OH, USA) was used in this study. The plate was processed by linear plane-
strain machining at room temperature using cutting depth of 150µm and tool velocity of 25mm/s 
for three different rake angles of +40°, +20° and 0°. The dimensions of resulting chips were 
typically 8mm×3mm×0.25mm. Control samples were prepared by cutting the bulk plate in 
8mm×3mm×1mm pieces using diamond saw. The nanograin chips and control sample were 
mechanically grinded by SiC paper and polished using polycrystalline diamond suspensions in 9 
and 3µm sizes (DP suspension P, Struers, Denmark) followed by a mirror finish by colloidal 
silica suspension (OP-U suspension, Struers, Denmark) using the polishing machine (Struers, 
Tegramin-25, OH, USA) and then were cleaned in acetone and ethanol for 20min in an 
ultrasound system. Oxide layer was chemically grown on all three nanograin chips and the 
control sample using the chemical method reported by Evance et al. [59]. Briefly, samples were 
soaked in the solution containing 5M sulfuric acid (VWR, BDH Aristar® Plus, Canada) and 
2.5M chromic acid (Sigma-Aldrich, MO, USA) at 70°C temperature for 30min and 1hr duration. 
Thermal treatment was also examined to grow the oxide layer on nanograin chips and the control 
sample. Thus, samples were thermally oxidized in air at 1000°C temperature for 15min and 
rapidly cooled to room temperature [60]. 
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3.2.2  Hardness measurement 
The Vickers hardness of control nanograin samples was measured using microhardness tester 
(Shimadzu, HMV-2 Series, Japan).   
3.2.3  Surface characterization 
3.2.3.1 Surface wettability 
To measure the wettability of surfaces (i.e., three types of nanograin chips and control sample 
before and after chemical and thermal treatments), sessile drop method was used by a drop shape 
analysis system (Kruss, DSA10, PA, USA). Deionized (D.I) water was dispersed on top of 
surfaces from a syringe, the drop image was recorded by a video camera and the contact angle of 
the drop was calculated.  
3.2.3.2 Surface topography  
Surface profile and roughness of untreated nanograin chips and coarse-grain sample  which have 
the mirror-finish surface was studied by optical surface profiler (Veeco NT3300 Optical Profiler, 
GA, US). Average roughness (Ra), root mean squared roughness (Rq) and maximum height of 
the profile (Rt) was measured and Ra was used to compare the surface roughness between 
different groups. Furthermore, surface topography and microstructure of all samples (i.e., three 
types of nanograin chips and control sample before and after chemical and thermal treatments) 
was characterized by scanning electron microscopy (SEM) (Jeol-JSM 6610 LV, Japan). A 
nanometer layer of palladium (pd) was sputtered on the surface before SEM imaging.  
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3.2.3.3 Surface chemistry 
Surface chemistry of all samples before and after thermal and chemical treatment was analyzed 
using X-ray Photoelectron Spectroscopy (XPS, ESCALAB 250 XI Thermoscientific, USA). In 
addition to survey spectra, high-resolution XPS spectra at Fe2p and Cr2p were acquired for 
control and nanograin samples.  
3.2.4 Cell viability and proliferation assay 
All samples were sterilized by soaking in 70% ethanol for 30min and subsequently washed with 
sterile PBS (Gibco®, NY, USA). MC3T3 cells at passage number 6 were seeded on the 
specimens at a density of 3×105 cells/ml. Cells were grown in MEM Alpha (1×) medium 
(Gibco®, NY, USA) containing 10% FBS and 1% Antibiotic-Antimycotic solution. 2ml of 
media was added in each well of the tissue culture plate and the plates were kept in a humidified 
incubator under 5% CO2 at 37°C. 
After 48hrs cell culture, the samples were washed with PBS, loaded with 1ml 10µM 
Calcein AM (life technologies™, NY, USA) solution and were incubated in (37°C and 5% CO2) 
for 30min before imaging.  Fluorescent images were taken to observe the live and attached cells 
using fluorescent microscopy (Olympus BX43, Japan). 
 Cell proliferation was assessed by a colorimetric assay using 3-(4, 5-dimethylthiazol-2-
yl)-2, 5-diphenyl tetrazolium bromide (MTT, CT02 MTT Cell Growth Assay Kit, EMD 
Millipore, Darmstadt, Germany). Cells were cultured for 1hr, 2hrs, 4hrs, 24hrs and 5 days at an 
initial seeding density of 3×105 cells/ml. After the determined incubation time, 0.01ml pre-
warmed MTT solution was added to each culture well containing 0.1ml fresh cell medium and 
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the cell culture plate containing MTT solution continued incubation for 4hrs under the same 
conditions. MTT solution has a pale yellow color which live cells cleave it to yield a dark blue 
formazan product. This transformation is catalyzed just by active cell mitochondria. Thus, the 
measurement of produced formazan can be an index of number of live cells.  After 4hrs 
incubation of cells with MTT, 0.1ml isopropanol with 0.04 N HCl was added to each well. The 
HCl converts the phenol red in tissue culture medium to a yellow color that does not interfere 
with MTT formazan measurement. The isopropanol dissolves the formazan to give a 
homogeneous blue solution suitable for absorbance measurement. The absorbance was measured 
at a wavelength of 570nm using microplate reader (BioTek® Synergy 2, VT, USA). 
 The morphology of MC3T3 cells adhered on substrates was probed by SEM after a thin 
layer of palladium (Pd) deposition by sputtering. For the SEM, cells were fixed with 2.5% 
glutaraldehyde (Sigma-Aldrich, MO, USA), dehydrated in a series of ethanol/DI water mixtures 
including 30%, 50%, 75%, 90% and 100% ratios, then, subjected to drying with 
hexamethyldisilazane (HMDS) (Alfa Aesar, MA, USA)/ethanol in 3:1, 1:1 and 1:3 volume 
ratios. The samples were dried in the hood overnight at room temperature. 
3.2.5 Statistical analysis 
For characterization tests (i.e., contact angle measurement, roughness measurement and hardness 
measurement) and cell culture study, three samples of each condition were examined and results 
were presented as mean values ± standard deviation (SD). Statistical analysis was conducted in 
Minitab® 16.1.0 (©2010 Minitab Inc. PA, USA) using the one-way analysis of variance 
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(ANOVA) test and post hoc Tukey’s HSD test. P-value <0.01 was considered statistically 
significant. 
3.3 RESULTS 
3.3.1 Hardness measurement 
Figure 4 shows the measured Vickers microhardness values of all four samples (i.e., control 
sample, 40°, 20° and 0° nanograin chips). Vickers microhardness of control sample showed 
194±21.7HV and nanograin samples showed 310±59HV, 385±81.97HV and 460±56.92HV for 
40°, 20° and 0° chips, respectively. These results demonstrated that decreasing the average grain 
size significantly increases the Vickers microhardness such that Vickers microhardness of 0° 
chip with average grain size of 42nm increased more than two times compared to bulk control 
sample that has 22µm average grain size. 
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Figure 4: Vickers microhardness for control and 0°, 20° and 40° chips 
 
 
 
3.3.2  Surface characterization 
3.3.2.1 Surface profile and roughness analysis 
Figure 5 shows the surface profile of all four samples (i.e., control sample, 40°, 20° and 0° 
nanograin chips) that characterized by optical profilometer. Small variation is observed in 
surface texture of the samples. Surface profile of 0° chip shows a fairly smooth surface with no 
significant dents and peaks while in control and two other nanograin chips (i.e., 20° and 40° 
chips), small uneven areas in nanometer scale are observed. Average surface roughness (Ra) of 
all samples shows less than 20nm, but there is a significant difference between the average 
surface roughness (Ra) of them (P-value<0.001). 
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Figure 5: Representative surface profile of A) Control sample, B) 40°chip, C) 20°chip and D) 0°chip 
 
 
 
Figure 6 shows the results on surface roughness of four samples. While control sample 
shows 19.2±1.1nm in average, three nanograin samples show 4±1.4nm for 0° chip, 5.4±0.91nm 
for 20° chip, and 7.1±0.88nm for 40° chip. As we described the nanograin sample preparation in 
earlier section (2.2.1), all samples were grinded and polished in a same manner. However, the 
surface roughness decreased in nanoscale over decreasing the average grain size. The slight 
difference in the surface roughness might be because of the difference in the hardness of samples 
causing slight change in the surface profile during surface polishing since the probability of 
forming dents is higher on surfaces with lower hardness. 
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Figure 6: Average surface roughness (Ra) of control sample and nanograin chips 
 
 
 
3.3.2.2 Surface topography characterized by SEM 
Since the surface profile analysis by optical profilometer is only applicable for shiny surfaces, 
SEM image was used to inspect detail surface topographies of all samples studied here (i.e., 
control sample, 40°, 20° and 0° nanograin chips, as well as chemically and thermally treated 
samples). Figure 7 shows the representative SEM images of untreated, chemically, and thermally 
treated control samples, 40°, 20° and 0° chips. Untreated surfaces show smooth and mirror-finish 
topography, no noticeable difference is observed in surface topography of four types of samples 
(Figure 7-A1, B1, C1 and D1). However, island-like structures, grooves and holes are appeared 
on the surface after 1hr chemical treatment. The average size of created islands is larger in the 
control sample (~>10µm) compared to nanograin chips. In nanograin chips, the average size of 
islands was reduced with the finer nanograin samples (i.e., smaller rake angle). In addition, while 
both the number and size of holes were increased over decreasing the rake angle from 40° to 0°, 
the depth of surrounding grooves was increased. Thus, surfaces became rougher in smaller 
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nanograin samples after chemical treatment (Figure 7-D2). The surface texture after thermal 
treatment is somewhat different from the surfaces observed in the samples chemically treated. 
New micro features were appeared on the surface after thermal treatment; however, the size and 
shape of them were substantially smaller than those observed in the chemically treated samples. 
The uniformity of surface microfeatures was increased in the finer nanograins. The 0° nanograin 
chip showed the uniformly distributed microfeatures with an average size of ~2µm that cover the 
surface, which is different from the control sample (i.e., random size of micro features with non-
uniform distribution). 
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Figure 7: SEM images of A) Control sample: 1. Untreated, 2. Chemical treated, 3. Thermal treated, B) 0° 
chip: 1. Untreated, 2. Chemical treated, 3. Thermal treated, C) 20° chip: 1. Untreated, 2. Chemical treated, 3. 
Thermal treated and D) 40° chip: 1. Untreated, 2. Chemical treated, 3. Thermal treated 
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3.3.3  X-ray photoelectron spectroscopy (XPS) analysis 
Chemical compositions of all four samples (i.e., control sample, 40°, 20° and 0° nanograin chips) 
before any surface treatment were analyzed by X-ray photoelectron Spectroscopy (XPS). Figure 
8A shows the survey spectra of these four samples. Identical peaks appeared in all four spectra 
including dominating peaks corresponding to elements of carbon, oxygen, chromium and iron 
and the lower peak corresponding to the nickel. High resolution spectra of Fe2p and Cr2p are 
presented in Figure 8B and Figure 8C, respectively. Fe2p spectra represented a double peak 
corresponding to free iron and iron oxide compositions. The XPS results for Cr2p region also 
indicated the presence of free chromium and chromium oxide compositions on the surface.  
 
 
 
 
 
 
Figure 8: A) Survey XPS spectra and B) High resolution XPS spectra of Fe 2p and C) Cr 2p for control sample and 
0°, 20° and 40° chips 
 
 
 
To study the chemical compositions of chemically and thermally treated nanograin chips 
and control sample, similar XPS spectra (i.e., survey, Fe2p and Cr2p) were acquired for them. 
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Similar to untreated samples, no noticeable differences were observed between the XPS spectra 
of control and nanorain chips after both thermal and chemical treatments. In both chemically and 
thermally treated samples, peaks corresponding to free iron and free chromium disappeared 
(Figure 9 and 10). In chemically treated surfaces, similar peaks to untreated surface were 
observed; however, the peaks corresponding to chromium oxide and iron oxide significantly 
intensified. 
 
 
 
 
 
 
Figure 9: A) Survey XPS spectra, B) High resolution XPS spectra of Fe2p and C) Cr2p for control sample and  0°, 
20° and 40° chips after chemical treatment 
 
 
 
In thermally treated surfaces, in addition to present peaks observed in untreated surfaces, 
a new peak corresponding to manganese compositions appeared on the surface and the peak 
corresponding to chromic oxide strongly intensified. 
 
 
 
36 
 
 
 
 
Figure 10: A) Survey XPS spectra, B) High resolution XPS spectra of Fe2p and C) Cr2p for control sample and 0°, 
20° and 40° chips after thermal treatment 
 
 
 
3.3.4  Contact angle measurement 
Figure 11 compares the contact angles measured for control sample and nanograin chips before 
and after surface treatment. The control sample shows 70.83±2.56° water contact angle and no 
significant difference is observed between the control, 40°, 20° and 0° chips before surface 
treatment (P-value=0.299). The contact angles of all samples, however, significantly were 
decreased (P-value<0.001) after 1hr chemical treatment. There is a trend that samples with 
smaller grain sizes show greater reduction of contact angles. The 0° chip presents a 
superhydrophilic surface (9±3.18° contact angle) while the control sample, 40° and 20° chips 
show contact angle of 28.75±0.35°, 26.75±3.1° and 19.5±1.4°, respectively. Water contact angle 
was also decreased after thermal treatment compared to the untreated samples (i.e., 50±1.2°, 
44.5±0.21°, 39±3.6° and 37±1.8° for control sample, 40°, 20° and 0° chips, respectively). While 
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the reduction rates were not significant compared to the samples chemically treated, a similar 
trend was observed in thermally treated samples, which means that samples with smaller average 
grain size show more hydrophilic surfaces.  
 
 
 
 
 
 
Figure 11: A) Representative image of water contact angle on 0° chip, B) Contact angle measurement of control 
sample and 0°, 20° and 40° chips before and after chemical and thermal treatment 
 
 
 
3.3.5 Cell viability and proliferation assay 
Figure 12 shows the mean value of MC3T3 cells viability on untreated, chemically treated and 
thermally treated samples that were evaluated using the MTT assay over five different periods 
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(1hr, 2hrs, 4hrs, 1day and 5 days). After 1hr, mean counts of optical density measurement were 
0.1086±0.023, 0.0875±0.0082, 0.0774±0.0078 and 0.056±0.001 for untreated 0°, 20°, 40° and 
control sample, respectively (P-value=0.011) indicating the higher initial cell attachment and 
viability for smaller grain size samples. This trend was kept for rest of time periods Proliferation 
rate during these five time periods does not show a noticeable difference between control and 
nanograin chips. In chemically treated surfaces, no significant difference is observed between 
samples in all five time periods. However, in thermally treated samples, it shows enhancement in 
cell viability by decreasing the average grain size. Both chemically and thermally treated 
samples demonstrate lower proliferation rate compared to untreated samples. 
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Figure 12. MTT assay for cell viability of control sample and 0°, 20°, 40° chips in A) Untreated, B) Chemically 
treated and C) Thermally treated conditions after 1hr, 2hrs, 4hrs, 24hrs and 5days 
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Figure 13 shows Calcein AM stained live cells cultured on the control sample and 
nanograin chips before and after surface treatments. Highest number of live cells was spread out 
on the untreated 0° surface. By decreasing the grain size in untreated samples, the cell growth 
and the fluorescent intensity became higher. In chemically treated surfaces, no significant 
difference is observed between number of live cells on nanograin chips and coarse-grain surface. 
However compared to untreated surfaces, the cell growth is lower in analogous chemically 
treated surfaces. In thermally treated surfaces, number of live cells is higher in 0° chip compared 
to control sample. The cell growth on thermally treated surfaces is noticeably smaller compared 
to analogous untreated surfaces. 
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Figure 13: Fluorescent images of Calcein AM stained MC3T3 cells after 48hrs culturing on A1) Control surface, 
A2) 40° chip, A3) 20° chip, A4) 0° chip, B1) Chemically treated control Surface B2) Chemically treated 40° chip, 
B3) Chemically treated 20° chip and B4) Chemically treated 0° chip, C1) Thermally treated control surface, C2) 
Thermally treated 40° chip, C3) Thermally treated 20° chip and C4) Thermally treated 0° chip 
 
 
 
Figure 14 shows SEM images of MC3T3 cells cultured on the control sample and 
nanograin chips before and after surface treatment. Cells on untreated samples fully spread and 
extend their cytoplasmic projections in multiple directions. Larger size of cells on nanograin 
chips compared to control sample imply their higher growth on nanograin chips. However, in 
both groups of surface treated samples, cells do not display fully flat shape similar to untreated 
surfaces. On chemically treated samples, cells extend their pseudopodia anchoring the rough 
surface in multiple directions. In chemically treated 0° chip which shows an extremely rough 
surface, the pseudopodia of cells attached on the surface are pretty elongated. On thermally 
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treated surfaces, cells have not been spread on the surface, they show a flat shape on control and 
40° samples while on 20° and 0° chips, cells demonstrate round shape with short pseudopodia 
extruded from their surfaces.  
 
 
 
 
 
 
Figure 14: SEM images of MC3T3 cells after 48hrs culturing on A1) Control surface, A2) 40°chip, A3) 20°chip, 
A4) 0° chip, B1) Chemically treated control Surface B2) Chemically treated 40° chip, B3) Chemically treated 20° 
chip and B4) Chemically treated 0° chip, C1) Thermally treated control surface, C2) Thermally treated 40° chip, C3) 
Thermally treatd 20° chip and C4) Thermally treated 0° chip 
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3.4  DISCUSSION 
Machining is a deformation process involving a wedge shaped tool which is advanced against a 
workpiece at a speed V. In this case, the is effective strain imposed on the material forming the 
chip is given by:  
 
ε=cosα/(3sinφ cos(φ-α)………………………………………………..(1) 
 
where α is the rake angle of the tool and Φis the shear angle. Plane-strain machining is a two-
dimensional SPD technique which can impose a high strain rate of the order of 103/s altering the 
material microstructure under a precisely controlled process via varying parameters of rake angle 
(α), depth of cut and tool velocity (Figure 15A)[61]. A summary of microstructure presentations 
of 0° and 20° chips produced by plane-strain machining, is demonstrated in Figure 15B-15C. 
The average grain size of 316L stainless steel is about 22µm while after plane-strain machining, 
it reduces to nanometer scale (e.g., 42nm in 0° rake angle)[58].  
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Figure 15: A) Schematic of plane strain machining with α° rake angle, B) OIM map of 20° chip, C) OIM map of 0° 
chip and D) OIM map legend [58] 
 
 
 
Refining the grain size is a well-known technique for strengthening materials. The 
mechanism of this phenomenon has been explained by Hall-Petch effect. Grain boundaries 
prohibit dislocation movements storing strains and increasing the material hardness[62]. 
Wiezorek et al. has demonstrated that grain refinement and stored strain is the main reason 
behind hardness and strength increase in 316L stainless steel after linear plane-strain  machining 
process[58].  
In addition to the hardness increase under plane-strain machining SPD technique, the 
biological functionality of the surface might vary because of refining the grain size in nanometer 
scale and altering the microstructure. Upon contacting material surface with the biological 
environment, a layer of water covers the surface. Based on the chemistry and hydrophilicity of 
the surface, water molecules might be dissociated and form hydroxyl groups on the surface or 
weakly bind to the surface. Subsequently, ions and proteins presenting in the medium adsorb on 
the surface. Surface properties (e.g., wettability, chemistry, and topology) determine types, level, 
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conformational arrangement and binding strength of these molecules on the surface. The focal 
attachments of cells to the adsorbed molecules induce specific signals transduced to the nucleus 
and determine the cell behavior [6, 63]. XPS spectra reveal no change in the chemical 
composition of the surface after SPD process of the plane-strain machining. In the iron XPS 
region (i.e., 700-730eV), peaks at 707.5eV and 710.9eV are shown corresponding to the Fe 
element and Fe2O3 composition, respectively. In the chromium XPS region (i.e., 560-600eV), the 
dominating peak at 576.7eV demonstrates the presence of Cr2O3 composition on the surface. The 
peaks at the nickel region including 852.8eV, 854eV and 856.9eV correspond to Ni, NiO and 
Ni2O3 compositions [64, 65]. The presence of these peaks show that an oxide layer forms on the 
surface. The thickness of this oxide layer should be in the nanometer scale because the elemental 
iron and chromium is detected in the XPS spectra. According to these observations, this surface 
oxide is the spontaneous nanometer oxide layer forming on the surface of stainless steel in the 
ambient air. Surface topography of nanograin chips and coarse-grain sample also revealed no 
significant difference. Besides, water contact angle did not show statistically significant 
difference between control sample and nanograin chips. Since surface chemistry and roughness 
of samples were identical, lack of change in water contact angle after refining the grain size is 
not unexpected. Results of MTT assay clearly suggest that 0° untreated chip demonstrates the 
highest MC3T3 cell viability during the short-term and long-term in vitro cell culture among all 
untreated and treated samples. Cells on untreated samples are in highly flattened form spreading 
their cytoplasmic extensions in multiple directions without showing any orientation; growth of 
cells on nanograin samples is higher than coarse-grained sample. 
After both chemical and thermal treatment, the peaks corresponding to the elemental Fe 
and Cr disappear implying growing the oxide layer on the surface. Similar to untreated surfaces, 
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after thermal and chemical treatment, no difference in the chemical composition of nanograin 
chips and coarse-grained sample is observed showing that grain structure does not change the 
chemical composition of grown oxides. Decreasing the water contact angle of samples after 
surface treatment can be explained by the hydroxyl groups formed on the surface (26). While we 
did not observe any significant change in the wettability of untreated control sample and 
nanograin chips, after surface treatment, 0° chip shows the highest amount of decrease compared 
to control and 40° and 20° chips. While samples show identical surface chemistry, the different 
surface roughness and topography of nanograin chips after surface treatment cause different 
surface wettability in them. The drop amount of water contact angle was significantly higher 
after chemical treatment compared to thermal surface treatment. Different surface topography 
and chemistry between formed oxides after each treatment should evince this difference. 
Guillamet et al., studied the surface structure of austenitic stainless steel after heat treatment in 
900-1100°C temperatures for 5-15min duration. They demonstrated αFe2O3, Cr2O3 and the spinel 
oxide close to MnCr2O4 are the main compositions of thermally treated samples. In our study, 
XPS results of thermally treated samples also shown in addition to the presence of peaks 
corresponding to Fe2O3 and Cr2O3, a new peak appears in 638-648eV region corresponding to 
manganese enrichment on the surface [60]. In thermally treated surfaces, cell viability decreases 
compared to the native stainless steel oxide, this observation may be due to the difference in 
surface chemistry of these oxides and appearance of manganese oxide composition on the 
surface. Jang et al., demonstrated that the incorporation of manganese composition into the 
surface titanium oxide layer diminishes osteoblast cell behavior [66]. 
After chemical treatment, the surface roughness remarkably increases and the island-like 
structure uniformly appears on the surface [67]; however, the size of islands significantly 
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decreases via reducing the grain size. Vorobiev et al., suggested an explanation for this 
observation such that grain boundaries actively undergo anodic dissolution and cathodic reaction 
occurs in the grains and oxide film grows on the surface [68]. Therefore, refining the grain size 
provides more grain boundaries covering the surface with small islands resulting in an entirely 
rough surface for 0° nanograin surface.  
It is expected that growing a stable surface oxide enhances the corrosion resistance and 
prevents toxic ion release [69, 70]. However, it is shown that the oxide film formed by chemical 
treatment results in an island-like structure with a non-uniform chemical composition and 
porosity within its depth (chromium-enriched surface). Therefore, chemically formed oxide on 
stainless steel reduces the corrosion resistance compared to the passive oxide naturally formed 
on the surface [67].   
Cell morphology on the naturally passive oxide and chemically formed oxide is 
significantly different. While cells on untreated nanograins and the control sample entirely 
spread on the surface, in chemically treated samples, cells are in polygonal morphology and 
attached on the surface using long cytoplasmic projections. This different morphology of 
MC3T3 osteoblast cells might be because of the change in cellular phenotype [71]; therefore, 
more cell studies needed to explain this behavior.  
3.5  SUMMARY AND CONCLUSION 
Ultra-fine grain 316L stainless steel samples were prepared by severe plastic deformation (SPD) 
using linear plane-strain machining technique. Samples were prepared in three different average 
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grain sizes in nanoscale range by using three different rake angles (i.e., 0°, +20° and +40°). 
Vickers microhardness was significantly increased after refining the average grain size. Oxide 
layers were grown on nanograin chips by chemical and thermal treatment. To systematically 
examine the naturally, chemically and thermally grown oxides on nanograin samples, surface 
roughness, topography, wettability and chemical composition of surfaces were characterized. 
Surface roughness and water contact angle (i.e., index of wettability) of nanograin and coarse 
grain samples remained in similar ranges of 3-20nm and ~70°, respectively. XPS results showed 
a natural oxide formed on nanograin samples with similar composition of the oxide formed on 
the coarse grain sample. After chemical treatment, a chromium enriched oxide with island-like 
topography formed on the surface and the wettability of surface significantly increased (i.e., 
contact angle ~ 10-30°). Refining the grain size creates oxides with smaller island-like structures 
showing rougher and more hydrophilic surfaces. After thermal treatment, micro-size oxide grains 
formed on the surface, the distribution of these grains became more uniform in nanograin 
samples with smaller average grain size. Manganese oxide compositions intensified in the 
composition of the thermally oxide layer formed on the surface. The viability and morphology of 
MC3T3 cells were studied on surfaces. The results of MC3T3 cell culture showed greatly 
improved cell adhesion and growth on the native passive oxide formed on 0° chip with the 
smallest grain size. Oxide formed on the surface of untreated samples demonstrated higher 
biocompatibility compared to both thermally and chemically treated surfaces.  
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4.0  TECHNIQUE 2: RAPID ELECTROSTATIC ENDOTHELIAL CELL SEEDING 
ON THIN FILM NITINOL 
4.1  INTRODUCTION 
Cardiovascular diseases (CVDs) are known the leading cause of death in the United States, a 
major part of this group of diseases are associated with morbidity in small-size blood vessels 
(i.e., <6mm)[72, 73]. For instance, coronary artery disease (CAD) is recognized the most 
common type of CVDs that leads to 380’000 deaths in the US, annually[74]. CAD is accounted 
for 1 in 4 deaths in the US and about $108.9 billion cost was estimated regarding to it[75]. Figure 
16 shows the schematic of coronary artery occlusion by plaque (i.e., atherosclerosis) that inhibits 
transferring sufficient oxygen and nutrition to the cardiac muscle. 
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Figure 16: The heart damage in coronary artery disease resulted from blockage of a coronary artery[38] 
 
 
 
Occlusion in small cerebral blood vessels and peripheral arteries are two other prevalent 
examples of small-size vascular diseases which result in disorder in providing the blood to the 
brain and lower extreme organs (e.g., kidney, stomach and legs), respectively [76-79]. About 8 
million Americans are affected by peripheral artery disease (PAD). It is claimed that the number 
of PAD around the world had a 23.5% rise from 2000 to 2010[80]. PAD occurrence increases 
with age and if it is left untreated, it might result to limb amputation; the risk of stroke and heart 
attack increases too. Bypass surgery is the typical treatment method to restore the blood flow in 
occluded vessels. In this surgery, a healthy blood conduit (i.e., autologous vessel) is supplied 
from another part of the body and is placed around the blocked artery. Autologous vessels, 
including saphenous veins and mammary arteries, remained the gold standard for coronary 
grafting. The saphenous vein has been extensively utilized as a vascular graft because of its 
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length and diameter, which are similar to those of coronary and femoral or popliteal arteries [81-
83]. Despite the high efficiency of autologous vascular grafts, there is limitations in providing 
needed amount of them such that patients might have not sufficient healthy veins for grafting 
owing to preexisting vascular disease or using healthy veins for previous surgeries[84]. 
Preparation of vascular graft from some other autogenous sources such as skin, pericardium or 
intestine have been examined but the results were not promising owning to early thrombosis, 
rupture or aneurysm occurrence[85, 86]. Arterial and venous allogenic grafts have been used as 
substitutes for small vascular grafts but the inflammatory reaction, calcification and limited 
availability are the major restricting factors for allografts. Xenograft has also been limited due to 
aneurysm formation, infection, thrombosis, calcification and risk of disease transmission and 
rejection [85, 86]. Therefore, to meet the high demands for vascular grafts, synthetic materials 
were also tested to develop vascular grafts. Among synthetic materials, expanded 
polytetrafluoroethylene (e-PTFE) and Polyethylene terephthalate (Dacron©) are two known 
polymers that are successfully used as vascular grafts. E-PTFE is an inert polymer with an 
electronegative charged luminal surface (similar to endothelium layer in the native blood vessel) 
that is antithrombotic and demonstrated patent results for lower limb bypass grafts (7–9 mm) and 
Dacron© demonstrated excellent result in large-diameter vascular grafts. However, both e-PTFE 
and Dacron© showed poor patency rates as small-caliber vascular grafts[86]. In a randomized 
trial to compare the PTFE with saphenous vein for femoropopliteral bypass, after 54 months, the 
patency rate for PTFE and saphenous vein is reported 37% and 70% respectively while after 6 
weeks both were 92%[87]. Implanted e-PTFE and Dacron© graft do not develop an 
endothelialized lumen spontaneously, leading to adhesion of platelets and development of a 
luminal fibrin layer that can lead to thrombosis.  
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In addition to thrombosis, other causes of vessel narrowing, such as intimal hyperplasia 
expedite the occlusion. Occurrence of thrombosis and restenosis result in the failure of vascular 
grafts in short term such that approximately 600’000 percutaneous coronary procedures are 
performed annually in the United States and nearly 25-40% of initially successful of these 
procedures fail within one year[88].  
Neointimal hyperplasia refers to proliferation and migration of vascular smooth muscle 
cells resulting in the thickening of arterial walls and decreased arterial lumen space (Figure 17). 
Damage to the arterial wall creates a series of biochemical events that lead to the recruitment of 
inflammatory cells, proliferation and migration of vascular smooth muscle cells, and collagen 
deposition and finally restenosis occurrence. The restenosis results in critical narrowing in 30% 
to 50% of patients after vascular grafts implantation[89]. 
 
 
 
 
 
 
Figure 17: Schematic of vascular smooth muscle cells migration and neointimal hyperplasia occurrence[90] 
 
 
 
Native blood vessels contain multiple cellular layers and this structure provides 
mechanical elasticity and a thrombo-resistant surface for blood vessels. Figure 18 shows the 
schematic structure of arteries including intima (squamous endothelial cells), media (vascular 
53 
 
smooth muscle) and adventitia (connective tissue). The endothelium in the intima layer plays an 
active role in preventing the thrombosis and platelet adhesion through providing a thrombo-
resistant barrier between blood and arterial wall; furthermore, it releases chemicals to control 
thrombosis, platelet activation and smooth muscle cells migration and proliferation leading to 
maintaining hemostasis through chemical regulation for example normal endothelial cells release 
nitric oxide that has an active role in maintaining the vascular hemostasis and preventing 
neointimal hyperplasia[91]. Therefore, the lack of endothelialization in the surface of synthetic 
vascular grafts or the native endothelium injury that occurs in percutaneous procedures during 
endovascular deployment result in increasing the thrombosis potential and restenosis and finally 
failure of the treatment.  
 
 
 
 
 
 
Figure 18: Schematic of artery structure[92] 
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Therefore, covering the surface of the vascular grafts with a layer of endothelial cells as 
exists in the intima layer of the native blood vessel is an strategy that is used to decrease the 
thrombosis[93-95]. Seeding the endothelial cells on the synthetic grafts first reported by Herring 
et al. for 6–mm Dacron© grafts[96]. The Endothelial seeding enhanced the patency rate after 4 
weeks to more than 3 times (76% vs. 22%). However, multiple limitations exist in endothelial 
cell seeding such as poor retention of the cells on the surface of biomaterials under blood flow 
shear stress, low degree of adhesion of cells, limitation of available cells number and time 
duration for harvesting and incubating cells to grow. Using biological glues such as the 
modification and coating of the surface with RGD (Arginyl-Glycyl-Aspartic acid) peptides, 
matrix proteins (e.g., fibronectin), growth factors or a combination of them is used to enhance 
the adhesion of endothelial cells but there are concerns about arising the thrombogenicity of the 
surface[97, 98]. 
Electrostatic cell seeding is an alternative technique to improve the efficiency of cell 
seeding in terms of number of attached cells and the amount of cell adhesion. In this method, a 
positive electrostatic charge is temporarily induced on the surface of the graft to promote 
endothelial cell adhesion. Biomaterials with an electrically charged surface have been studied 
and it is demonstrated that the adhesion of endothelial cells is enhanced on the electrically 
charged substrates[99]. Bowlin et al., suggested using electrostatic force to seed the endothelial 
cells inside the small diameter e-PTFE tubes, they demonstrated the endothelial cell maturation 
accelerated and cell retention after implantation enhanced[100-102]. They developed a system 
for seeding the endothelial cells on the e-PTFE vascular graft via electrostatic force. The system 
is a capacitor-like structure which consists of an internal conductor within the graft. The ends of 
the graft are sealed around the internal conductor. The external conductor consists of a stainless 
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steel cylinder that was bored centrally and placed around the graft such that the internal electrode 
is placed at the center of it (Figure 19A). An electrical potential is applied across the internal and 
external conductors to induce a positive luminal surface electrostatic charge on the vascular graft 
as the dielectric material within the capacitor. Figure 19B shows the schematic of capacitor 
model of electrostatic endothelial cell seeding on the e-PTFE vascular graft. A temporary 
positive electrical charge was induced on the e-PTFE surface as the positive electrically charged 
electrode and endothelial cells which have negative electrical charge deposit on it. They found 
the optimal electrostatic transplantation conditions (+1V voltage and 16min duration) and 
exposure of cells to this system under optimal condition led to seeding efficiencies of up to 90% 
[101]. 
 
 
 
 
 
 
Figure 19: A) Electrostatic cell seeding set-up for e-PTFE graft, B) Capacitor model for electrostatic endothelial cell 
seeding[101] 
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In this study, the goal is to accelerate the endothelial cell seeding and improve the 
adhesion and growth of the seeded cells on the surface of thin film nitinol using electrostatic 
transplantation technique. This cell seeding procedure is aimed to perform on the thin film 
nitinol deployed inside the intravascular catheter right before the endovascular surgery. This 
study suggests a novel in vitro system for the rapid endothelialization of thin film nitinol. 
Advantages of thin film nitinol such as superelasticity, low profile and grown hemocompatible 
oxide on its surface along with the presence of a uniform endothelial layer on its surface 
candidate it as a promising endovascular graft for the treatment of small-diameter vascular 
diseases.  
4.2 METHODS 
4.2.1 Design, manufacture and test of electrostatic endothelial cell transplantation device  
Thin film nitinol was deposited on silicon wafer using DC sputter deposition technique. The 
sputter chamber pressure and the argon pressure were kept 5×10-8 and 1.5×10-3Torr, respectively. 
A 10nm thick native oxide layer forms the surface of thin film nitinol and by using a chemical 
surface treatment as explained in the introduction section (1.1.2), a 100nm titanium oxide grows 
on the surface[103]. Water contact angle significantly enhances after chemical treatment because 
of the grown oxide layer; therefore, a superhydrophilic surface is gained after the surface 
treatment. Untreated and superhydrophilic thin film nitinol were used as negative and positive 
electrodes, respectively.  
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The dimension of electrodes was 3mm×3mm and they were fixed parallel to each other 
with 2mm distance in a 24-well tissue culture plate (Figure 20A). The substrate with positive 
induced electric charge was placed at the bottom of the culture plate and connected to the power 
supply via copper wire (Figure 20A). The distance between two parallel electrodes was filled 
with the cell suspension solution. 
 
 
 
  
 
 
Figure 20: A) Parallel capacitor set-up, B) The schematic of induced electric charge and electrical field in a parallel 
capacitor 
 
 
 
The induced electric charge (Q) on the electrode surface and the induced electric field (E) 
(Figure 20B) were estimated using the following equations:  
 Q=C×V                                                                                                                                     (2)          
 
E= V
d
                                                                                                                          (3) 
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Where V is the applied voltage, d is the distance between two electrodes and C is the total 
capacitance which is defined by: 
 
C=  kε0A
d
                                                                                                                                                                           (4)  
 
where ε0 is the permittivity constant (8.85×10-12), A is the surface area of electrodes and k is the 
dielectric constant which is around 80 for the cells suspension medium. We can consider the 
cells suspension medium as the dielectric since no electric current was recorded during the 
experiment. We neglect the capacitance of the surface oxide layer due to the trivial thickness of 
native and grown oxide (i.e., nanometer scale) against 2mm distance. Based on the above 
equations, the induced electric charge and electric field in each experiment are calculated. 
In the second prototype, the thin film nitinol was deployed inside the 6Fr catheter and the 
catheter was placed in a microincubator providing a temperature of 37°C and 5% CO2 pressure. 
The catheter was connected to a flow loop containing a small pulsatile pump creating a flow of 
endothelial cell suspension medium. The nitinol wire passed from the center of microcatheter 
while the thin film nitinol was rolled inside the catheter. Two sides of the catheter were perfectly 
sealed (Figure 21). One end of nitinol wire was connected to the negative terminal of voltage 
supply and one side of the thin film nitinol which faced the catheter wall contacted with copper 
conductor connecting to the positive terminal of the power supply ensuring no electrical 
connections existed between the components. 
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To evaluate the induced electric field (E) and electric charge (q) between the electrodes in 
the cylindrical capacitors, Gauss’ law is used according to the following equations: 
 
∫E. dA = ∑q
ε0
                                                                                                     (5) 
E = q
2πrLε0
                                                                                                        (6) 
 
V= ∫ E. dr =ba  q2πε0 (lnba)                                                                                (7) 
 
C= 2πε0L(lnb/a)                                                                               (8) 
 
where A is the cylindrical surface with length L and diameter r, V is the electrical potential and 
C is the capacitance. 
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Figure 21. Components of electrostatic endothelial cell seeding on the thin film nitinol placed inside the 6Fr catheter 
 
 
 
4.2.2 Experimental design 
To simultaneously evaluate multiple factors which can affect the level of cell seeding and 
behavior of seeded cells, the Taguchi method is used to design the experiments. Taguchi method 
remarkably reduces the number of experiments that are required to model the response function 
compared with the full-factorial design of experiments. The parameters which can potentially 
61 
 
affect this electrostatic cell seeding process include: the cell suspension solution, the substrate 
chemistry, applied voltage and the incubation time. The voltage value determines both induced 
electric field and electrostatic charge. The range of values of these parameters is given in Table 
1. For both voltage and time parameter, four levels will be taken and for each of suspension 
solution and substrate chemistry parameters, two levels will be considered.  
 
 
 
Table 2: Electrostatic cell seeding parameters and their levels 
 
 
Level Time (hrs) Voltage (V) Suspension solution Substrate 
1 0 0.1 PBS TFN 
2 2 1 Cell medium solution STFN 
3 6 3 ---- ---- 
4 24 6 ---- ---- 
  
 
 
 In addition to the above mentioned experiments which were performed in the parallel 
capacitor-like set-up, in cylindrical capacitor-like intravascular catheter set-up which have been 
explained above, experiments in 1V, 5V and15V were performed in cell medium suspension 
solution. These experiments were performed on superhydrophilic thin film nitinol substrate for 
30min duration and the analysis was performed right after the experiment (i.e., no incubation 
time). 
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Analysis of variance (ANOVA) technique will be performed to identify the significant 
factors that affect the number of attached cells. 
4.2.3 Testing the morphology, attachment and the viability of seeded endothelial cells  
BAEC (Bovine Aortic Endothelial Cells; Lonza, NJ, USA) were grown in the medium 
consisting of Endothelial Cell Basal Medium (EBM)-2 (Lonza, NJ, USA) and EGM-2 
SingleQuot Kit Suppl. & Growth Factors including (Hydrocortisone 0.02%, FBS2%, 
VEGF0.05%, hFGF-B2%, IGF-1 0.05% and HEGF 0.05%, GA-1000 0.05%) (Lonza, NJ, USA). 
These cells at passage number 9 at a density of 2×105 cells/cm2 were suspended in the medium 
solution or PBS solution. After electrostatic cell seeding, the samples were rinsed thoroughly 
with PBS and stained with Calcein AM (life technologies™, NY, USA). Three samples in each 
condition were used and in each sample five spots were randomly picked and the number of 
attached live cells were counted and used for the analysis (i.e., totally 15 images).   
Besides, LIVE/DEAD® cell viability assay (Life technologies, NY, USA) are performed to 
determine the live attached cells and dead cells using fluorescent microscopy (Olympus BX43, 
PA, USA).  Both morphology and proliferation of adhered cells were evaluated using SEM after 
sputtering a thin layer of palladium (Pd). For SEM imaging, cells were fixed with 2.5% 
glutaraldehyde (Sigma-Aldrich, MO, USA), dehydrated in a series of ethanol/DI water mixtures 
including 30%, 50%, 75%, 90% and 100% ratios, then, subjected to drying with 
hexamethyldisilazane (HMDS) (Alfa Aesar, MA, USA)/ethanol in 3:1, 1:1 and 1:3 volume 
ratios. The samples were then dried in the chemical hood overnight at room temperature.  
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4.3  RESULTS 
4.3.1  Electrostatic endothelial cell seeding in parallel capacitor-like set-up 
Since we have two 4-level control factors (i.e., Time and voltage) and two 2-level control factor 
(i.e., cell suspension solution and substrate), Qualitek-4 software (software for automatic design 
and analysis of Taguchi experiments) has selected L-16 array without considering the 
interactions. The experiemental plan is shown in the Table 3, each row of this table shows an 
experiment with different combination of the parameters levels. 
Table 3: Experimental plan using L-16 orthogonal array 
Experiment number Time (hrs) Voltage (V) Solution Substrate 
1 0 0.1 Cell medium TFN 
2 0 1 Cell medium TFN 
3 0 3 PBS       STFN 
4 0 6 PBS STFN 
5 2 0.1 Cell medium STFN 
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Table 3(continued) 
6 2 1 Cell medium STFN 
7 2 3 PBS TFN 
8 2 6 PBS TFN 
9 6 0.1 PBS TFN 
10 6 1 PBS TFN 
11 6 3 Cell medium STFN 
12 6 6 Cell medium STFN 
13 24 0.1 PBS STFN 
14 24 1 PBS STFN 
15 24 3 Cell medium TFN 
16 24 6 Cell medium TFN 
 
 
 
The results of induced surface electrostatic charge in each of Taguchi designed 
experiments have been calculated based on the formula (1-3) and demonstrated in Table 4. 
 
 
  
Table 4: Induced electrostatic charge and electrical field in the designed experiments 
 
 
Experiment number Electrostatic charge (µC) Electrical field (V/m) 
1 3.18×10-7 50 
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Table 4 (Continued) 
 
 
2 3.18×10-6 500 
3 9.54×10-6 1500 
4 1.9×10-5 3000 
5 3.18×10-7 50 
6 3.18×10-6 500 
7 9.54×10-6 1500 
8 1.9×10-5 3000 
9 3.18×10-7 50 
10 3.18×10-6 500 
11 9.54×10-6 1500 
12 1.9×10-5 3000 
13 3.18×10-7 50 
14 3.18×10-6 500 
15 9.54×10-6 1500 
16 1.9×10-5 3000 
 
 
 
The representative fluorescent imaging of attached Calcein AM stained endothelial cells 
under conditions determined in the designed experiments for parallel capacitors is shown in 
Figures 22, 23, 24 and 25. For each condition, a representative fluorescent image of the control 
sample (i.e., the similar condition but without applying voltage) is shown as well. 
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Figure 22: Representative fluorescent images of Calcein AM stained cells on STFN substrate in cell medium 
solution: A) 0.1V-2hrs, B) 1V-2hrs, C) 3V-6hrs, D) 6V-6hrs; A’ and B’) 0V-2hrs (control for A and B), C’ and D’) 
0V-6hrs (Control for C and D) 
 
 
 
 
 
 
Figure 23: Representative fluorescent images of Calcein AM stained cells on STFN substrate in cell medium 
solution: A) 0.1V-2hrs, B) 1V-2hrs, C) 3V-6hrs, D) 6V-6hrs; A’ and B’) 0V-2hrs (control for A and B), C’ and D’) 
0V-6hrs (Control for C and D) 
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Figure 24: Representative fluorescent images of Calcein AM stained cells on TFN substrate in cell medium solution: 
A) 0.1V-0hr, B) 3V-24hrs, C) 6V-24hrs, D) 6V-6hrs; A’ and B’) 0V-0hr (control for A and B), C’ and D’) 0V-24hrs 
(Control for C and D) 
 
 
 
 
 
 
Figure 25: Representative fluorescent images of Calcein AM stained cells on TFN substrate in PBS solution: A) 
0.1V-6hrs, B) 1V-6hrs, C) 3V-2hrs, D) 6V-2hrs; A’ and B’) 0V-6hrs (control for A and B), C’ and D’) 0V-6hrs 
(Control for C and D) 
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Qualitek-4 software uses the results of the fluorescent imaging in each experimental 
condition described in Table 3 and the effect of changing the electrostatic cell seeding 
independent parameters (i.e., voltage, time, substrate chemistry and the suspension solution) on 
the average number of attached cells per mm2 were analyzed based on standard statistical 
analysis. The results of the average number of attached cells per mm2 are shown in Figure 26 
while the levels of each parameter are changed. The average number of attached cells per mm2 
slightly increases on superhydrophilic thin film nitinol (~48) compared to untreated thin film  
nitinol (~41) (Figure 26A). The average number of attached cells per mm2 increases through 
changing the voltage from 0.1V up to 1V and it reduces by decreasing the voltage from 1V to 
6V; therefore, the average number of attached cells per mm2 is the highest in 1V (Figure 26B). 
The result of the average effect of the cell suspension solution on the number of attached cells in 
Figure 26C shows that this value is slightly higher in cell medium solution (~49) compared to it 
in the PBS solution (~40). Ultimately, Figure 26D shows the effect of the time parameter. The 
diagram trend line shows that the average number of cells increases over time as expected. 
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Figure 26: Diagram of average effect A) substrate, B) voltage, C) cell suspension solution and D) time duration on 
the number of attached cells per mm2 
 
 
 
Analysis of variance (ANOVA) technique was performed to identify the significant 
factors that affect the number of attached cells. Thus, voltage and time with contribution 
percentage 34.4% and 36.1% and F-ratio of 25.17 and 26.37 were respectively identified as the 
two dominant factors. While cell suspension solution shows 5.56% contribution with F-ratio of 
12.6 and the substrate parameter shows 0.97% contribution with F-ratio of 3.03 (critical F-ratio 
,F*2,3,0.05 =9.55). Sources of errors including the variability within the groups or unexplained 
random error contribute 22.3% of results. 
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SEM images in Figure 27A show endothelial cells attached on STFN substrate after 2hrs 
incubation in the cell medium show a few nanospikes emerging on the rounded-up cell bodies 
but upon applying 0.1V, the number and length of these nanospikes significantly increase 
(Figure 27B) while under 1V with the same condition, these cells become noticeably flat on the 
surface (Figure 27C). 
 
 
 
 
 
 
Figure 27: Representative SEM images of attached endothelial cells on STFN substrate in the cell medium solution 
after 2hrs under A) 0V (Control), B) 0.1V and C) 1V 
 
 
 
By increasing the incubation time from 2hrs to 6hrs, the cell morphology presumably 
becomes more flat and the nanospikes emerging on the surface remarkably lengthens (Figure 
28A). Applying 3V causes cells to become more flat but cell membrane pitting significantly 
occurs indicating the cell damaging (Figure 28B). By increasing the voltage up to 6V, the level 
of disintegration and pitting in cell membrane significantly increases (Figure 28C). 
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Figure 28: SEM images of attached endothelial cells on STFN substrate in the cell medium solution after 6hrs under 
A) 0V (Control), B) 3V and C) 6V 
 
 
 
Similar to STFN substrate, the cell membrane damage (i.e., cell membrane disintegration 
and pitting) under 6V, has been also observed in TFN substrate in both PBS and cell medium 
solutions (Figure 29B and Figure 30B) while no cell membrane damage was observed in TFN 
substrate under 3V (Figure 29A and 30A). 
 
 
 
 
 
 
Figure 29: SEM images of attached endothelial cells on STFN substrate in the cell medium solution after 6hrs under 
A) 0V (Control), B) 3V and C) 6V 
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Figure 30: SEM images of attached endothelial cells on TFN substrate in PBS solution under: A) 3V-2hrs and B) 
6V-2hrs 
 
 
 
4.3.2 Electrostatic endothelial cell seeding in intravascular catheter 
Table 5 shows the value of applied electrical voltage, induced electrical field and the induced 
electrostatic charge on the STFN substrate placed in the cylindrical capacitor set-up of the 
intravascular catheter. Induced electrostatic charge and electric field is noticeably higher in the 
parallel capacitor set-up compared to the cylindrical capacitor set-up of the intravascular 
catheter, for instance, under 1V voltage, the induced electric field in parallel capacitor set-up, 
and intravascular catheter set-up is 500V/m, 1.022 V/m, respectively. 
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Table 5: Electrostatic cell seeding experiments 
 
 
Experiment number Voltage(V) Electrostatic charge (µC) 
 
Electrical field (V/m)  
1 1           0.136×10-6 1.022 
2 5           0.68×10-6 5.11 
3 15           2.04×10-6 15.33 
 
 
 
Figure 31 shows the Live/Dead assay results and the SEM images of attached cells on 
superhydrophilic thin film nitinol substrate placed in intravascular catheter set-up while 1, 5 and 
15V is applied. Figure 32 demonstrates the fluorescent intensity of live attached cells under 1, 5 
and 15V. Number of attached live EC increases under 1V and 5V while the number of live cells 
under 15V significantly decreased compared to control condition (0V). The highest number of 
attached cells is observed in 5V condition. The morphology of cells under the condition of 
applying electrical voltage is similar to the control sample but under 5V, multiple podia form on 
the surface of cell showing the advancement of cell maturation in this condition. 
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Figure 31: Live/Dead® cell viability assay of endothelial cells on the STFN substrate: under A1-B1) 15V, A2-B2) 
5V, A3-B3) 1V and A4-B4) 0V (control) and SEM images of endothelial cells on the STFN substrate: C1) 15V, C2) 
5V, C3) 0.5V and C4) 0V(control) 
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Figure 32: Fluorescent intensity of attached live Calcein AM stained endothelial cells under applying (0V, 
0.5V, 5V and 15V conditions) 
 
4.4 DISCUSSION 
The cell is the basic structural unit of all living organisms, which contains a watery cytoplasmic 
solution and surrounded by a cell membrane. One of the important features of biological cells is 
having electrical nature due to the exchange of electrically charged ions across the cell 
membrane and showing the electrical potential of its interior relative to the exterior. Cell 
membranes consist of phospholipid bilayer structure and ion channels (i.e., K and Cl ion 
channels) and proteins are embedded across this phospholipid bilayer (Figure 33).  
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Figure 33: Schematic of cell membrane structure[104] 
 
 
 
Phospholipid bilayer in the cell membrane is an insulator layer which acts as the 
dielectric which separate two electrically conductive regions of the cytoplasm and the 
extracellular fluid. Therefore, the cell can be modeled by a capacitor as shown in Figure 34. 
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Figure 34: Schematic of the biological cells modeled as a capacitor[105] 
 
Electric fields exist in many biological systems and influence cell signaling and many 
cellular behaviors and biological events. Therefore, electrophysiological features of cells vary 
with the surrounding physiological environment. At rest, most cells have typically a potential 
around -40 to -80mV indicating that they are dominated by K or Cl permeability. In a study by 
Jongsma et al., the membrane potential of isolated human vascular endothelial cells, capacitance 
and input resistance were measured -16.3±12.7mV, 53.9±5.5 pF and 2.3±1.3GΩ[106]. 
Based on the electrophysiological features of cells, the cells can be seen as charged 
particles and electrostatic cell seeding can be modeled as electrophoretic deposition (EPD). EPD 
is a process that colloidal charged particles suspended in a solution and they migrate under the 
influence of an electric field generated between two electrodes, thus, they are deposited onto an 
electrode based on the electrostatic charge they have (Figure 35). In the electrostatic cell seeding 
set-up that we used in this study, the thin film nitinol plays as the positive electrode and the 
endothelial cells that are suspended in the PBS or cell medium solution play as the electrostatic 
negatively charged particles. 
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Figure 35: Schematic of electrophoretic deposition[107] 
 
 
 
Avgustinik et al., described the factors affecting the amount of deposited particles during 
EPD process in cylindrical, coaxial electrodes. These factors include the length(l) and radius(a) 
of the deposition electrode, the radius of the coaxial counter electrode (b > a), the particle mass 
concentration in the suspension (C), permittivity (ε), the zeta potential (ξ), the viscosity of the 
suspension (η), the electric field strength (E) and the deposition time (t). Therefore, the deposit 
yield (w) can be estimated through the following equation[108]:  
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w=l.E.ε.ξ.C.t
3.ln�𝑎𝑎
𝑏𝑏
�.η                                                                                              (9) 
 
In this study, by using Taguchi DOE method, the effect of four factors (i.e., voltage, 
substrate, cell suspension medium and incubation time) in the parallel electrostatic cell seeding 
set-up were studied. Since parallel capacitor set-up is a simpler set-up to perform the electrostatic 
cell seeding experiments compared to cylindrical capacitor intravascular set-up, it was used to 
study the effects of electrostatic cell seeding parameters (i.e., incubation time, substrate, cell 
suspension solution and applied voltage) using Taguchi DOE methods. Design of experiment 
method allows evaluating multiple factors simultaneously and finding the optimal condition for 
accelerating and improving the endothelial cell seeding on the thin film nitinol substrate. 
PBS and cell medium were tested as the cell medium suspension, in addition to the 
difference of their dielectric constant that is not significant; the main difference between them is 
the presence of proteins in the cell medium. Our results demonstrated that the average number of 
attached cells was higher when the cell medium solution was used. Proteins in biological serum 
effectively play role in the cell adhesion process such that proteins and biomolecules first adsorb 
on the surface of materials and then cells attach on these pre-adsorbed proteins. Proteins are large 
biomolecules and contain multiple functional groups with electrostatic charge; therefore, the 
electrostatic charge of the substrate can affect the type and the arrangement of the deposited 
proteins and subsequently impact their function, the ligand binding and cell signaling.  
The estimation of average effect of voltage showed that increasing voltage up to an optimal 
range can enhance cell attachment but increasing it beyond this point decreased the number of 
attached cells. The applied voltage affects both the induced electric field and substrate 
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electrostatic charge. McCaig et al., showed electric fields in the range of 75–100mV/mm−1 with 
voltage of 1.5–2.0mV enhanced the elongation and migration of endothelial cells[109]. If the 
applied voltage across the capacitor becomes too large, the dielectric breaks down and results in 
a short circuit. In addition, high voltage and high electric field can damage the cell membrane. 
For instance, in this study, in cylindrical capacitor intravascular set-up, under 15V applied 
voltage, the number of attached cells decreased compared to the control sample (0V applied 
voltage).   
By increasing time incubation, the results demonstrated that the number of attached cells 
increased which showed that over time the seeded endothelial cells did not detach from the 
surface and they grow and their number increases.  
The average number of attached cells was slightly higher on the STFN substrate 
compared to the TFN. The grown oxide layer on thin film nitinol acts as an insulating surface 
layer and enhance the wettability of the surface leading to improve the cell adhesion. 
4.5 SUMMARY AND CONCLUSION 
High incidence of restenosis in the current small-diameter vascular grafts caused by lack of 
endothelialization and thrombosis occurrence in them result in a pressing need to develop a novel 
vascular graft resistant to restenosis. Thin film nitinol shows unique favorable properties such as 
superelasticity, shape memory, biocompatibility and anti-thrombogenicity in a low profile 
(~10µm) which make it a candidate for small diameter vascular graft application. In this study, 
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electrostatic cell seeding was suggested in order to seed endothelial cells on the surface of thin 
film nitinol to enhance the resistance of the TFN surface against the restenosis. Endothelial cells 
possess electrostatic negative charge on their surfaces and under uniform electric field can be 
considered as electrically charged particles in electrophoresis process. Therefore, by inducing 
positive electrostatic charge on the surface of thin film nitinol, it is postulated to expedite the 
seeding of endothelial cells with negative charge on the surface. To assess and optimize the 
parameters in electrostatic cell seeding, a parallel capacitor set-up with TFN substrate as the 
positive electrode were used and using Taguchi design of experiment, the effects of applied 
voltage, substrate and cell suspension solution were evaluated. The results demonstrated that the 
number of attached endothelial cells increases by applying voltage and over time the detachment 
does not occur. Number of attached cells increase on the superhydrophilic TFN substrate and in 
medium solution (i.e., with the presence of serum protein) increased compared to TFN substrate 
and PBS solution, respectively. 1V applied voltage with induced electrostatic charge of 3.18×10-
6µC and induced electric field of 500V/m showed the highest endothelial cell attachment in 
parallel capacitor set-up while the condition of 5V voltage with induced electrostatic charge of 
0.68×10-6µC and induced electric field of 5.11V/mm-1 (i.e., much lower amount compared to the 
parallel capacitor set-up) showed the highest endothelial cell attachment in cylindrical set-up 
intravascular set-up.  
Electrostatic endothelial cell seeding for superhydrophilic thin film nitinol deployed   in a 
6Fr catheter demonstrated efficacy in accelerating endothelial cell attachment. In future studies, 
the phenotypic features of attached endothelial cells and the in vivo studies of implanted 
electrostatic endothelial cell seeded thin film nitinol will be evaluated.   
82 
5.0  TECHNIQUE 3: COATING ELECTROSPUN SILK ON THIN FILM NITINOL 
5.1 INTRODUCTION 
The high incidence and cost of small vascular diseases creates a pressing need to develop an 
effective treatment method and qualified replacement for these non-functional vessels [110-112]. 
Transcatheter endovascular therapy has made a significant progress in treating occlusive vascular 
diseases via presenting various minimally invasive devices. However, when these devices are 
used to treat small vascular diseases, e.g., pediatric cardiovascular diseases, there still remains 
critical risks in terms of the device delivery, restenosis occurrence and hemocompatibility[113, 
114]. As an example, coarctation of the aorta (CoA) is a narrowing occurrence in a short segment 
of aorta, where the main artery distributes the oxygenated blood from the left ventricle to all 
parts of body (Figure 36). It is a relatively common defect that accounts for 5-8% of all 
congenital heart defects[115]. If CoA is not diagnosed and treated in a timely manner, it is 
developed into the congestive heart failure (CHF) or hypertensions which both are among 
common pediatrics cardiovascular diseases. 
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Figure 36: Schematic of coarctation of the aorta (CoA) disease[116] 
 
 
 
Open surgery (i.e., eliminating the narrowed section and connecting ends of the arteries 
along with using medication) is a common method to treat newborns diagnosed with CoA. 
Alternative treatment options specifically applied for older children are transcatheter-based 
therapies that include a dilation of the narrowed site using an angioplasty balloon or the 
placement of a vascular stent in the narrowed site[117-120]. While both surgical and 
transcatheter-based procedures are widely used for treating CoA, there are a few potential 
complications such as possible damages to the downstream organs such as kidney because of the 
blood flow interruption during surgery, CoA recurrence after balloon dilation due to the vessel 
damages, and restenosis occurrence at the narrowed site especially after stent deployment. In 
addition, systematic hypertension, aortic valve abnormalities, and aortic aneurysm formation 
could be other concerns that can occur after the conventional CoA treatments[115, 121, 122]. All 
84 
 
these complications are driving force to seek for a safer and more effective treatment method for 
CoA treatment. The ideal device for treatment of CoA could be a low-profile endovascular 
device, which can (1) be safely delivered with a micro delivery catheter (e.g., < 3Fr), (2) be 
deployed in small blood vessels minimizing damages on the vessel wall, (3) reduce or prevent 
any potential thrombosis and neointimal hyperplasia with the device thickness of less than 
~20μm, and (4) promote rapid endothelialization of the blood-contacting surface.   
A high-quality thin film nitinol (TFN) can be fabricated by vacuum sputter deposition 
technique. Thin film nitinol exhibits superelasticity behavior (i.e., reversible deformation to high 
strain around 5% at human body temperature) even with the substantially reduced thickness 
down to a few micrometers. TFN can be collapsed in remarkably smaller size catheters due to its 
low-profile dimension and easily be delivered through highly tortuous and narrow vascular 
system. In addition, the superelasticity of TFN enables the device to be deployed by itself 
without any additional actuation systems such as ballooning. This material has also demonstrated 
excellent biocompatibility and high corrosion resistance with its ultra-smooth surface as 
implantable vascular devices over decades, which are beneficial for treating small vascular 
diseases[69, 123, 124]. While TFN has shown superior superelastic behavior with 
thromboresistance characteristics, but its surface endothelialization is not so rapid and sufficient 
in order to be used as a small vascular graft application. Therefore, thin film of silk nano fibers 
can be used as a novel luminal coating layer for facilitating rapid and confluent endothelial cell 
growth. Silk is a fibrous protein that is mostly synthesized in epithelial cells that line in the 
glands of insects such as spiders (e.g., Nephila clavipes) and silkworms (e.g., Bombyx mori). 
Silkworm cocoon silk contains two structural proteins, the fibroin heavy and light chains which 
are glued together with sericin protein in forming the cocoon silk. Silk fibroins are purified from 
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sericins by boiling silk cocoons in an alkaline solution (i.e., degumming). Silk has been 
established as a biomaterial for a wide variety of applications, for example, it has been used as 
sutures for centuries. Silk has beneficial properties such as excellent biocompatibility, 
biodegradability and sterilizability. Moreover and shows high processability such that silk 
solutions can be used to form films, gels, sponges and non-woven mats[125]. Figure 37 shows 
the general processing steps and the final possible forms of silk from silk cocoon source.  
 
 
 
 
 
 
Figure 37: The degummed silk fibers can be processed into silk cords or formed into aqueous silk fibroin solution 
and it can be processed into non-woven silk fibers, sponges, gels and films 
 
 
 
Silk fibroin can be successfully electrospun into nanofiber forms; electrospinning process 
is a known process to form fibers with nanosclae diameters from various polymers. A typical 
electrospinning setup consists of three components: a high voltage supplier, a capillary needle, 
and a collector (Figure 38). During electrospinning, the polymer solution is suspended from a 
needle and a high voltage is applied to it; therefore, the suspended polymer droplet becomes 
charged and electrostatic repulsive force counteracts the surface tension and the droplet is 
stretched; at a critical point a stream of liquid erupts from the surface. This point of eruption is 
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known as the Taylor cone. As a result, a fiber jet ejects from the apex of the cone and accelerates 
towards the collector. 
 
 
 
 
 
 
Figure 38: Schematic illustration of electrospinning setup[126] 
 
 
 
In electrospinning, multiple factors have been found to control fiber formation in this 
process such as concentration, viscosity, surface tension, electrostatic conductivity of the 
polymer solution, applied electrical voltage, distance between tip and collector and the 
temperature. To generate uniform nanofibers, an optimal combination of these electrospinning 
parameters should be selected. 
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Electrospun silk demonstrated an excellent substrate for the cell growth mimicking the 
function of native extracellular matrix [127]. In native tissue, the extracellular matrix is mainly 
composed of fibrous proteins, including collagens, elastin, fibronectin, and laminin (Figure 39). 
The diameter of these structural ECM proteins (50 to 500nm) is about 1–2 orders of magnitude 
smaller than the cells. Nanofibers to more adequately simulate ECM geometry can be produced 
by electrospinning. 
 
 
 
 
 
 
Figure 39: Fibers of extracellular matrix(ECM)[128] 
 
 
 
This study aims to fabricate a low-profile composite endograft using thin layers of nitinol 
and silk. The silk nanofibers have been deposited on the TFN substrates using electrospinning 
technique and the feasibility of using thin film silk as a novel coating for facilitating rapid and 
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confluent endothelial cell growth has been explored. Therefore, the functionality, 
thrombogenicity as well as endothelial cell (EC) and smooth muscle cell (SMC) responses were 
evaluated. 
5.2 METHODS 
5.2.1 Preparation and characterization of thin film nitinol  
The thin film nitinol (TFN) was prepared by a direct current (DC) sputter deposition technique as 
previously described[129]. Briefly, 6µm thick films were deposited on 4" silicon wafer as the 
substrate having 5000Å thick silicon oxide layer. The sputter chamber pressure and the argon 
pressure were 5×10-8 and 1.5×10-3Torr, respectively. In order to prepare TFN specimen with 
dimensions of 1cm×0.6cm for fabricating TFN-S endograft, a chemical etching process along 
with a conventional photolithography method was used to create patterns on the sputtered TFN 
(Figure 40A). AZ-4620 positive photoresist with around 5µm thickness was used to define 
patterns and completely protect the TFN layer before the chemical etching. The etchant solution 
with a mixture of hydrofluoric acid (HF), nitric acid (HNO3) and DI water with volume ratios of 
1:1:20 was used and the chemical etching process approximately lasted 6min to etch through the 
TFN with 6µm thickness[130]. The resultant etched film was crystallized at 500°C for 120min in 
a vacuum less than 10-7Torr and mechanically removed from the silicone substrate. The phase 
transformation behavior and crystallinity of TFN material was studied using differential scanning 
calorimeter (DSC) and X-ray diffractometer (XRD), respectively.  
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5.2.2 Preparation of electrospun silk 
Bombyx mori cocoon (provided from Uljin-Nongwon, Republic of Korea) was degummed to 
remove sericin and other impurities. It was boiled at 95°C with sodium carbonate (0.2% w/w), 
(Daejung Chemical & Metals Co, Republic of Korea, 7541-4405) and sodium oleate (0.3% 
w/w), (Kanto Chemical Co, Japan, 37225-01) for 2hrs, and then it was rinsed thoroughly with 
deionized (DI) water to remove the impurities. Then, it was dissolved in 9.3 M LiBr (Samchun 
Chemical, Republic of Korea, L1106) solution. This solution was dialyzed against DI water for 3 
days to eliminate LiBr using dialysis tubing cellulose membrane (Sigma-Aldrich, US, D9402-
100FT). After dialyzing, the solution was freeze-dried (Eyela, Japan, FDU 2100) and then 
dissolved in 98% formic acid (JUNSEI Chemical Co, Japan, 25010-0350) at 10% (w/v) 
concentration for electrospinning. 
5.2.3 Fabrication of integrated TFN/silk endograft 
Using a direct electrospining of thin silk layer onto the TFN, 6μm-thick sputter-deposited 
superelastic TFN and 10μm thick electrospun samples were integrated. Figure 40B shows 
process details on the direct electrospinning of silk onto the TFN. An electrospining set-up was 
comprised of high voltage power supply, syringe pump, metal nozzle and a metal drum collector 
(NanoNC, Republic of Korea, ESR200RD). A SF/formic acid solution in 12mL syringe was 
continuously fed to the tip of the charged metal nozzle. The TFN was cut into a small piece and 
attached on the surface of the drum. An electric field was applied between the nozzle tip and the 
90 
 
drum collector. The applied voltage was fixed at 20kV and the distance of 15cm was maintained 
while the pumping flow rate was maintained at 1mL/hr.  
 
 
 
 
 
 
Figure 40: (A) Patterned TFN for the endograft fabrication and (B) Schematic diagram of electrospining of silk 
fibroin (SF) on the surface TFN 
 
 
 
The morphology of the electrospun silk deposited on TFN was analyzed by scanning 
electron microscopy (SEM, JEOL JSM-6610LV, Japan).  
After sputter deposition and subsequent thermal annealing process, the stand alone TFN 
was achieved by splitting silicon substrate followed by mechanical delamination process.  
5.2.4 Radial force measurement 
The radial force exerted from TFN-S endograft was measured with a custom-built test set-up on 
a vibration isolation table. A brass tube with 2mm internal diameter was used to simulate the 
(A) (B) 
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small-caliber vascular geometry. It was cut in half along its longitudinal axis and placed over a 
force measurement system that was equipped with an accurate load cell (FSB200, FUTEK, 
Advanced Sensor Technology, Inc., CA, USA). The TFN-S device (15mm long with 3.14mm 
diameter) was deployed into the half-cut brass tube to measure the device’s radial force (Fradial). 
The device was tested five times to evaluate its radial force accurately.  
The radial force exerted from the TFN-S device was also estimated by calculating the 
bending moment produced by the integrated TFN-S device. The radial force was estimated using 
the approximation presented by Chun et al. [131]: 
 
Fradial = ( 𝐸𝐸
1−𝜈𝜈2 . 124. h3).1𝑟𝑟. 𝑤𝑤𝑙𝑙                                                                                 (10) 
 
where r is the tube radius (1mm), l is the axial length of the rolled film (15mm), w is the film 
width (3.14mm), E is Young’s modulus of the austenite phase of nitinol (83GPa), ν is Poisson’s 
ratio (0.33), and h is the film thickness (6μm).  
5.2.5  In vitro cell culture and cell adhesion study 
Specimen of e-PTFE, Dacron® and integrated TFN-S were prepared in 1cm×0.6cm dimensions. 
All the samples were sterilized by immersion in 70% ethanol for 30min, then, they were 
transferred to a 12-well tissue culture plates (Becton Dickinson and company, NJ, USA) and 
washed with sterile PBS (Gibco®, NY, USA).  BAEC (Bovine Aortic Endothelial Cells; Lonza, 
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NJ, USA) at passage number 7 were seeded at a density of 4×105 cells/cm2 on the samples. Cells 
were grown in the medium consisting of Endothelial Cell Basal Medium (EBM)-2 (Lonza, NJ, 
USA) and EGM-2 SingleQuot Kit Suppl. & Growth Factors including (Hydrocortisone 0.02%, 
FBS2%, VEGF0.05%, hFGF-B2%, IGF-1 0.05% and HEGF 0.05%, GA-1000 0.05%) (Lonza, 
NJ, USA). BASMC Cells (Bovine Aortic Smooth Muscle Cells; Lonza, NJ, USA) at passage 
number 5 were grown in MCDB131 (1×) medium (Cellgro®, VA, USA) including L-glutamine 
(1%), 10% FBS, Antibiotic-Antimycotic solution (1%) and 50 mg/ml ascorbic acid-2-phosphate. 
In each well of tissue culture plate, 2mL of media was added at the beginning of the experiment. 
The plates were placed in a humidified incubator at 37°C and 5% CO2 for 48 hrs. The samples 
were rinsed thoroughly with PBS and stained with Calcein AM (life technologies™, NY, USA) 
and the fluorescence intensities were measured by fluorescent microscopy (Olympus BX43, PA, 
USA) as an index of live cells. Both morphology and proliferation of adhered cells were 
evaluated using SEM after sputtering a thin layer of palladium (Pd). For SEM imaging, cells 
were fixed with 2.5% glutaraldehyde (Sigma-Aldrich, MO, USA), dehydrated in a series of 
ethanol/DI water mixtures including 30%, 50%, 75%, 90% and 100% ratios, then, subjected to 
drying with hexamethyldisilazane (HMDS) (Alfa Aesar, MA, USA)/ethanol in 3:1, 1:1 and 1:3 
volume ratios. The samples were then dried in the chemical hood overnight at room temperature. 
5.2.6  Dynamic whole blood test  
The TFN-S endograft was rolled, collapsed in a 5Fr catheter (The INFINITI, Cordis, CA) and 
deployed in a silicone tube with 1.5mm internal diameter (Platinum-Cured Silicone Tubing, 
Cole-Parmer, IL). The silicone tube was connected to the pulsatile pump (Harvard apparatus, 
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MA) and all circulatory environments were treated with heparin before the application of blood. 
100mL of fresh whole human blood was circulating in the tube for 30min while the flow velocity 
was 0.3m/s and the tube containing the device was placed in the water bath at 37°C temperature 
(Figure 41). The samples were dried at air and coated with a thin layer of palladium (Pd) for 
SEM imaging. The SEM images were used to check the clot formation on the samples.  
 
 
 
 
 
 
Figure 41: Dynamic whole blood test set-up equipped with a pulsatile flow pump, water bath, and the heparinized 
silicone tubing 
5.2.7 Statistical analysis 
Values of fluorescent intensity regarding to attached endothelial and smooth muscle cells were 
expressed as the mean value ± standard deviation (SD). Statistical analysis was performed for the 
experiment using one-way analysis of variance (ANOVA) test and Tukey’s HSD test by 
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Minitab® 16.1.0 (©2010 Minitab Inc. PA, USA) and P-value<0.01 was considered statistically 
significant.  
5.3 RESULTS 
5.3.1 Material properties of TFN 
The XRD result of TFN measured at room temperature showed a predominant single peak at 2θ 
= 42.5° corresponding to (1 0 0) peak of the B2 austenite phase. It indicates the structure of 
annealed thin film is crystallized with the austenite phase structure at room temperature. DSC 
thermogram of TFN shown during cooling and heating operations demonstrated that two peaks 
are detected, one is observed during heating from -20°C to 80°C which is assigned to the 
transformation from martensitic phase to the austenitic phase. Austenite start temperature (As) 
equals to 10.09°C and the austenite finish temperature (Af) is 23.66°C. One other peak is 
appeared during cooling the specimen corresponding to the transformation from austenitic phase 
to the martensitic phase (i.e., martensite start temperature (Ms) = 20.06°C and martensite finish 
temperature (Mf) = 4.66°C). 
5.3.2 Prototype fabrication 
After sputter deposition and subsequent thermal annealing process, the stand alone TFN was 
achieved by splitting silicon substrate followed by mechanical delamination process. Figure 42A 
shows the SEM image of the cross section in TFN-S prototype created by a direct deposition of 
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silk onto TFN using electrospinning technique. Electrospun silk can be attached without any 
delamination. The SEM image in Figure 42B shows well-distributed electrospun silk layer with 
the thickness of fibers ranging approximately from 0.36 to 0.67μm (i.e., 3D scaffold for rapid 
endothelialization). Figure 42C shows the cylindrical shape of TFN that was manufactured using 
stress induced permanent deformation process. Once the electrodeposited silk layer has been 
coated on TFN, the whole device was collapsed into a 3Fr micro delivery catheter as shown in 
Figure 42D. No noticeable film damages or mechanical deformation were observed during both 
collapsing and deployment.  
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Figure 42: Device prototype images; A) SEM micrograph of integrated TFN/electrospun silk, B) The magnified 
structure of the electrospun silk, C) Integrated TFN/silk prototype, D) The collapsed integrated TFN/silk device into 
a 3Fr micro delivery catheter 
 
 
 
5.3.3  Radial force evaluation 
The theoretical prediction of the radial force of the TFN-S endograft (4μN) agrees well with the 
experimental data (3.8μN). This assessment result implies that there will be no migration of the 
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device under the typical blood flow conditions observed in a small vasculature[131]. Results of 
radial force measurement demonstrated that there was no significant difference between radial 
forces of thin film nitinol and the TFN-S within the range of the load cell (i.e., ± 0.0001N); 
adding the thin layer of electrospun silk did not increase the radial force. The TFN-S device 
demonstrated no migration under the flow velocity of 0.3m/s in 2mm diameter tube (n=3).  
5.3.4  Cell adhesion and viability studies 
5.3.4.1 SEM image analysis 
Figure 43A, 43B and 38C qualitatively compare both the number and morphology of the 
endothelial cells (ECs) attached on Dacron®, e-PTFE and TFN-S samples after 48hrs, 
respectively. Figure 43 shows each of these substrates presents a different topography for cells, 
the e-PTFE is formed from nodes around 10µm width connected with fibrils while Dacron® is 
composed of ~ 20µm woven fibers and electrospun silk represents a porous 3D mesh composed 
of slender fibers spread in random directions. ECs attached on both Dacron® and e-PTFE 
samples were mostly observed in spherical shape and fixed on the surface by short and thin 
cytoplasmic digitations or filopodia. However, attached cells on the electrospun silk surface had 
spread out in fusiform morphologies showing major podia around the cells. Figure 43D, 43E, 
and 38F show how smooth muscle cells (SMCs) attached on Dacron®, e-PTFE and TFN-S 
samples after 48hrs, respectively. SMCs were well spread out on all three surfaces and 
manifested their cytoplasmic extensions in multiple directions.  
 
 
 
98 
 
 
 
 
Figure 43: SEM images of the attached endothelial cells (ECs) on A) Dacron®, B) e-PTFE and C) TFN-S and the 
attached smooth muscle cells (SMCs) on D) Dacron®, E) e-PTFE and F) TFN-S 
 
 
 
5.3.4.2 Fluorescent microscopy image analysis 
Figure 44 shows representative fluorescent microscopy images of Calcein AM stained 
endothelial cells (44A-C) and smooth muscle cells (44D-F) on Dacron®, e-PTFE and silk 
surfaces, respectively. The number of viable endothelial cells significantly increased on silk 
surfaces (Figure 44C) compared to Dacron® (Figure 44A) and e-PTFE (Figure 44B). Similarly, 
the number of smooth muscle cells was higher on electrospun silk (Figure 44D-F). 
Figure 45 shows average fluorescent intensity of live Calcein AM stained ECs and SMCs 
attached on three different materials. TFN-S demonstrated greatly increased levels of 
fluorescence intensities as compared to either e-PTFE or Dacron® samples. As shown in Figure 
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44A and B, the TFN-S material showed significantly higher fluorescent intensities for both ECs 
and SMCs compared with either e-PTFE or Dacron® samples (P-value<0.001). Average 
fluorescent intensity for TFN-S was 1342±1025 a.u/mm2 for ECs and 1252.74±990 for SMCs, 
which are more than twice of the total intensities observed in either e-PTFE or Dacron®.  
 
 
 
 
 
 
Figure 44: SEM images of the attached endothelial cells (ECs) on A) Dacron®, B) e-PTFE and C) TFN-S and the 
attached smooth muscle cells (SMCs) on D) Dacron®, E) e-PTFE and F) TFN-S 
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Figure 45: Average fluorescence intensity measurement of Calcein AM stained A) endothelial cells (ECs) and B) 
smooth muscle cells (SMCs) attached on TFN-S, e-PTFE, and Dacron® samples 
 
 
 
5.3.5.6 Dynamic whole blood test  
Figure 46 shows the representative SEM images of Dacron®, e-PTFE and TFN-S surfaces after 
30min under dynamic whole blood flow, shown in different magnifications. Qualitative analysis 
of scanning electron microscopy data demonstrated substantially reduced thrombosis on TFN-S 
as compared to either Dacron® or e-PTFE. SEM images for Dacron® (Figure 46A, D, and G) and 
e-PTFE (Figure 46B, E, and H) showed that almost fully covered blood clots on the surface and 
the deposited blood products were dense. The thicknesses of the deposited blood clots roughly 
range from a few micrometers to a few hundred micrometers. These deposited layers were 
composed of both fibrin and platelet micro-particle (PMP) formation (i.e., highly activated 
platelets aggregation)[132] with occasional red and white blood cells visible as well. Although 
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blood clot was also observed on the TFN-S surface, the total deposition was substantially lower 
than either e-PTFE or Dacron®.  
 
 
 
 
 
 
Figure 46: Representative SEM images of  hemocompatibility results after 30 min whole blood circulation, three 
different magnifications (×800, ×1500 and ×5000): Dacron® (A, D, G), e-PTFE (B, E, H) and TFN-S (C, F, I) 
 
 
 
5.4  DISCUSSION 
A novel low-profile endovascular graft is fabricated and tested that contains thin film nitinol and 
thin electrospun silk layer, specifically targeted for treating small vascular diseases. In vitro cell 
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culture was performed to evaluate cellular behavior of both endothelial and smooth muscle cells, 
as well as built up an in vitro circulation model using a pulsatile pump, silicone tubing, and 
whole blood in order to compare a short-term (early) thrombotic response of various endograft 
materials including TFN and silk (TFN-S). A short-term in vivo swine test was also performed to 
assess biological interaction between thin film nitinol and vascular wall.  
The patency rate of commercially available synthetic vascular stent grafts (e.g., e-PTFE 
and Dacron covered devices) was significantly reduced in small vascular applications less than 6 
mm in diameter. While these synthetic vascular stent grafts have demonstrated successful 
outcomes for treating large-diameter blood vessels, they show undesirable results if used in 
diseased small-diameter blood vessels. However, the majority of vascular diseases occur in 
small-diameter blood vessels; therefore, suitable vascular stent graft specifically for small-
diameter blood vessels is urgently needed. The primary reasons behind this failure are mostly 
associated with the surface interaction with blood and blood vessel wall, which includes 
thrombogenicity and insufficient (or late) endothelialization, as well as the occurrence of 
excessive neointimal hyperplasia resulting in stent restenosis[133, 134]. Although the exact 
reasons of both thrombosis and intimal hyperplasia with a small-diameter vascular stent graft are 
poorly understood, recent studies reveal that a rapid endothelialization of the graft surface 
minimizing its thrombogenicity have been considered as a successful strategy to enhance the 
patency rate of vascular grafts[135, 136]. Therefore, most important criteria for the success of a 
vascular stent graft specifically used in small-diameter blood vessels include: (1) the capability 
of the rapid endothelialization, (2) slow or minimized smooth muscle cell growth (i.e., reduced 
neointimal layer formation), and (3) anti-thrombogenicity of the device’s surface exposed to the 
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blood stream. Our new device could synergistically enhance both mechanical and biological 
functions of the endograft by integrating thin layers of nitinol and silk.  
The size of endograft was markedly reduced only using two thin layers of nitinol and 
electrospun silk without any additional backbone structure (e.g., stent or reinforcement). This 
unique feature is specifically important for small vessel endograft applications, because the 
backbones typically increase the bulkiness of the device. The increased dimension of 
endovascular device in small blood vessels is known to cause local blood flow disturbances, 
which may increase the probability of potential thrombosis or blood vessel occlusion. All 
hemodynamic parameters (e.g., flow velocity, wall shear stress, and flow patterns) involve in 
modulating expressions of endothelial cell genes and proteins which determine the formation of 
the intimal hyperplasia[137]. Since the thickness of endografts specifically used in small-
diameter blood vessels can noticeably change hemodynamic parameters, low-profile endografts 
are favorable in the aspect of keeping the blood flow and forces similar to that in the native blood 
vessels. The total thickness of the TFN-S is only 16µm, which is roughly 6.25-12.5 times thinner 
than either e-PTFE or Dacron® graft materials (i.e., typically 100-200µm thick). In addition, the 
TFN-S device does not require a backbone that is typically 80-150µm thick.  
While the reduced dimension of the device is favorable, it is not always free from the 
device migration because the radial forces are reduced with the lack of backbone structure. 
Although a backbone structure helps prevent endograft migration, both empirical and 
experimental radial force data showed that the TFN-S endograft has sufficient radial force 
without any backbone or additional reinforcement to overcome the device migration caused by 
typical blood flow shear stress in small vasculature [138]. This is possible due to thin film nitinol 
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unique superelastic property even in low dimensions. In addition, the low-profile attribute of the 
TFN-S device could significantly reduce the size of the delivery catheter (i.e., ID=0.67mm), 
which is critical for treating small vascular diseases. Therefore, the TFN-S endograft could be 
delivered via a 3Fr catheter and deployed in the vascular system up to 3mm in diameter.   
In addition to the advantageous physical characteristics of TFN-S, the electrospun silk 
covered the luminal surface of the endograft showed better anti-thrombogenic behavior 
compared to both Dacron® and e-PTFE. Furthermore, in vitro cell culture studies on the TFN-S 
endograft materials demonstrated that both the number of attached endothelial cells and their 
spread morphologies on the electrospun silk were superior to both Dacron® and e-PTFE. 
The number of viable SMCs attached on its surface also showed higher numbers on TFN-
S than those on either e-PTFE or Dacron®. A pristine surface was acquired without damages on 
the vessel wall after the TFN-S device deployment in vivo. This result showed that there would 
be no (or minimized) stent-induced injury and wound healing process. Even though the 
gravitationally seeded SMCs have more cells attached on the surface, there would be no triggers 
of the wound healing process. While the SMC affinity is one of the important factors to be 
considered as SMC growth and further neointima growth, there are more complex mechanisms 
in neointima growth and restenosis. For example, there are several complex mechanisms from 
the migrated and proliferated cells from the wall, originated SMCs from the adventitial 
fibroblasts, bone marrow or circulating cells. The neointima growth by SMCs is controversial 
and more research is needed to define the detail mechanisms of SMC attachment on the graft 
materials[139, 140]. Our in vitro cell culture study results provide the proof-of-concept data 
about the reaction of electrospun silk compared to e-PTFE and Dacron® samples to the ECs and 
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SMCs which are the two main biological cells involving in restenosis formation[141, 142]; 
however, to discern the restenosis progress in these grafts, more in vivo data will be needed. 
5.5 SUMMARY AND CONCLUSION 
A novel composite endograft was manufactured via integrating thin layers of nitinol and 
electrospun silk (TFN-S) aiming small-diameter vascular graft applications. 
TFN-S demonstrated a remarkably low-profile endograft (i.e., ~16µm) with radial force of 
3.8µN resulted from thin film nitinol superelasticity. This radial force suffices to prevent 
migration under blood flow of small-diameter blood vessels without need to use vascular stent 
backbones. In vitro experiments showed electrospun silk (i.e., luminal surface covering) 
significantly decreased thrombus and improved endothelialization compared to two conventional 
vascular grafts (i.e., Dacron® and e-PTFE). The proof-of-concept in vitro testing results suggest 
that TFN-S could be promising candidate materials for small-diameter vascular grafts. 
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6.0  TECHNIQUE 4: MICROPATTERNED THIN FILM NITINOL COVERED 
CAROTID ARTERY EMBOLIC PROTECTION STENT 
6.1 INTRODUCTION 
Carotid artery disease is a major cause of stroke in the United States. Atherosclerosis occurrence 
and stenosis in the carotid artery inhibit proper blood flow to the brain leading to a serious brain 
damage, in addition, the risk of dislodgment and embolization from the atherosclerosis plaque 
and the occlusion of cerebral micro vessels exist and can lead to an ischemic stroke (Figure 47). 
Stroke is the leading cause of mortality and morbidity in the United States such that 
approximately 795,000 people suffer from a stroke annually and 15%-20% of these strokes is 
associated to carotid artery stenosis[143, 144]   
107 
 
 
 
 
Figure 47: A) carotid artery, B) normal carotid artery and C) Carotid artery stenosis[145] 
 
 
 
Carotid endarterectomy (CEA) is the standard treatment for carotid artery stenosis and 
around 100’000 CEA procedures are performed annually in the US alone[146]. The CEA 
procedure begins with a longitudinal arteriotomy of carotid artery and removing the plaque and 
finally closing the cut (Figure 48). However, after the surgery, there is the risk of re-narrowing of 
artery either immediately or over time and also there is the risk of embolization and thrombosis 
occurrence during the procedure. 
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Figure 48: The process of carotid endarterectomy[147] 
 
 
 
Carotid angioplasty and stenting is an alternative to the open surgery particularly for 
patients at high risk for the open surgery. It includes a dilation of the narrowed site using an 
angioplasty balloon or the placement of a vascular stent in the narrowed site. Vascular stent 
restores the blood flow through the blocked or narrow arteries but although these treatments have 
had relative success, they suffer from several drawbacks such as the cost, the risk of recurrence 
and the possibility of intimal vessel wall damage. In-stent restenosis is typically seen 3 to 6 
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months after the stent implantation and results in the failure of the procedure. During in-stent 
restenosis, the thickening of scar tissue underneath the lining of the artery and the migration of 
smooth muscle cells lead to the blockage of the blood flow. 
  In addition, the risk of distal embolization of atheromatous material still remains and this 
risk increases upon stent implantation and balloon dilation. Therefore, various types of embolic 
protection devices (EPDs) have been designed to use in order to reduce the risk of stroke in the 
carotid artery stenting procedure. Figure 49 shows multiple examples of embolic protection 
devices for capturing and removing the debris of atheromatous material. However, no 
randomized studies prove the effectiveness of the EPDs, for example, the efficacy of GaurdWire 
distal protection device (Figure 49) in a trial of randomized 500 patients showed no 
improvement[148]. 
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Figure 49: Examples of filter-type embolic protection devices (EPDs)[149] 
 
 
 
While the FDA has approved several bare metallic, self-expanding stents to treat carotid 
stenosis, it has not approved any covered stents for carotid artery applications. The pore size in 
conventional stents is larger compared to the size of embolic material, thus, the presence of a 
cover can trap the embolic material at source and reduce their propagation. A porous cover does 
not block the side branches and keeps the normal perfusion into branch vessels. A CE-marked 
covered stent is the CGuard system that consists of metallic stent covered with an ultra-thin 
polyethylene terephthalate (PET) mesh. A 30 days clinical trial in patients undergoing carotid 
artery stenting with CGaurd system demonstrated the safety and efficacy of this device [150]. 
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In this study, micropatterned thin film nitinol is proposed to be used as the covering 
membrane in stent for treating carotid artery stenosis. Thin film nitinol shows low profile, 
superelasticity and controllable micropatterned surface. In vitro studies are performed to evaluate 
the feasibility of micropatterned TFN as carotid artery covered stent in terms of capturing the 
embolic particles and interacting with endothelial cells.   
6.2 METHODS 
6.2.1 Preparation and characterization of micropatterned thin films of nitinol 
To create micropatterned thin film nitinol, the sputter deposition technique along with a lift-off 
process introduced by Chun et al., has been used[130]. Briefly, positive photoresist (PR) AZ 
5214 was deposited on a silicon wafer via spin coating technique and by using a chromium mask 
and UV exposure; six different patterns (e.g., diamond shape) were developed on it (Figure 50-
1). Then, a reactive ion etching was used to create trenches around the photoresist (50µm depth) 
(Figure 50-2). Next, photoresist was removed (Figure 50-3) and two layers of copper and SiO2 
were subsequently deposited on the surface (Figure 50-4). The thin film of nitinol was deposited 
on the top of silicone layer using hot-target sputter deposition technique with the thickness of 
6µm (Figure 50-5). The copper sacrificial layer was removed and the deposited thin film of 
nitinol was subsequently removed from the top of the silicon layer (Figure 50-6). Finally, the 
film was crystallized at 500°C for 120min in a vacuum of less than 1×10-7Torr. The resultant thin 
film nitinol showed an austenite finish temperature (Af) of almost 34°C. Scanning electron 
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microscopy (SEM) (Jeol-JSM 6610 LV, Japan) was used to observe the morphology of the 
micropatterned thin film nitinol. Besides, porosity percentage of each sample were calculated 
using SEM images and MATLAB R2015a (MathWorks, MA, USA) image analysis.  
 
 
 
 
 
 
Figure 50: Micropatterned thin film nitinol fabrication process : 1) Positive photoresist (PR) deposition and 
photolithography to create patterns, 2) Reactive ion etching to create trenches around the photoresist, 3) PR is 
removed, 4) deposition of copper layer and silicon layer, 5) Sputter deposition of thin film nitinol and, 6) copper and 
silicon layers are removed 
 
 
 
6.2.2 In vitro testing of the efficiency of micropatterned thin film nitinol samples to 
capture embolic particles 
A bench-top flow loop was used for the in vitro testing of the efficiency of micropatterned thin 
film nitinol samples to capture embolic particles which is illustrated in Figure 51. It consists of 
silicone tubing (Platinum-Cured Silicone Tubing, Cole-Parmer, IL, USA) with inner diameter of 
6.5mm which is close to the average human carotid artery dimensions[151]. To model the carotid 
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artery stenosis, microspheres (Cospheric, CA, USA) in diameter of 53-63µm in two different 
weight loads (i.e., 10mg and 30mg) were homogenously dispersed in 500mg water-soluble poly 
(vinyl alcohol) (PVA) glue (Lineco®, MA, USA) and the homogenous suspension was uniformly 
deposited with the length of 14mm on the surface of the internal wall of the silicone tube. 
Micropatterned thin film nitinol was rolled and placed inside the commercially available nitinol 
vascular stent (Zilver Vascular Self Expanding Stent, Cook Medical, Bloomington, IN). The thin 
film nitinol covered stent was deployed in the silicone tube right on top of the suspension 
containing fluorescent microspheres. The silicone tube was connected to the pulsatile pump 
(Harvard apparatus, MA) and deionized water was circulating at 402 and 510mL/min and  65 
and 85 beats per minute (bpm) in the tube for 30min[152]. The tube containing the device was 
placed in the water bath at temperature 37°C. Flowmeter (OMEGA, FLR1000 series, CN, 
USA) and pressure meter (PressureMAT, PendoTECH, NJ, USA) are placed adjacent to the 
carotid artery model to monitor the flow condition. At the ends of of flow circuit, a filter 
(Component Supply Co Inc., Fl, USA) with 105µm porosity dimension and 32% open area is 
placed which captures the released particles. The microspheres captured by the filter were 
imaged by fluorescent microscopy (Olympus BX43, Japan).  
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Figure 51: A) Schematic of flow loop in vitro set-up for carotid artery model, B) Flow loop in vitro set-up for 
carotid artery model 
 
 
 
6.2.3  In vitro cell culture 
Specimens of micropatterned thin film nitinol and solid thin film nitinol (i.e., control sample) 
were prepared in 1cm×1cm dimensions. All the samples were sterilized by immersion in 70% 
ethanol for 30min, then, they were transferred to a 12-well tissue culture plates (Becton 
Dickinson and company, NJ, USA) and washed with sterile PBS (Gibco®, NY, USA).  BAEC 
(Bovine Aortic Endothelial Cells; Lonza, NJ, USA) at passage number 5 were seeded at a 
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density of 2×105 cells/cm2 on the samples. Cells were grown in the medium consisting of 
Endothelial Cell Basal Medium (EBM)-2 (Lonza, NJ, USA) and EGM-2 SingleQuot Kit Suppl. 
& Growth Factors including (Hydrocortisone 0.02%, FBS2%, VEGF0.05%, hFGF-B2%, IGF-1 
0.05% and HEGF 0.05%, GA-1000 0.05%) (Lonza, NJ, USA). 2ml of media was added in each 
well of the tissue culture plate and the plates were kept in a humidified incubator under 5% CO2 
at 37°C. 
6.2.3.1 Actin staining and fluorescent imaging  
For the staining of F-actin, Alexa Fluor® 488 Phalloidin (ThermoFisher scientific, PA, USA) was 
used. After 48hrs cell culture, the samples were washed with PBS, fixed in 3.7% formaldehyde 
solution in PBS for 10min at room temperature and then each sample was extracted using 
acetone at –20°C for 3 to 5min. Subsequently, the samples were loaded with the fluorescent 
phalloidin washed with PBS and fluorescent images were taken using fluorescent microscopy 
(Olympus BX43, Japan). 
6.2.3.2 Quantification of endothelial cell elongation and alignment 
To quantitatively evaluate cell elongation and orientation, each phalloidin stained cell was 
visualized as an elliptical shape and the ratio of the major elliptic axis of individual the stained 
cells with respect to the horizontal axis was measured using MATLAB R2015a (MathWorks, 
MA, USA) image analysis. Moreover, the angle between the major axis of each individual cell 
with respect to the long axis of the micropattern was measured as the alignment angle using 
MATLAB R2015a (MathWorks, MA, USA) image analysis. Five samples of the micropatterned 
thin film nitinol and control samples were used and in each sample four spots were randomly 
picked and used for the analysis (i.e., totally 20 images).   
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6.2.3.3  MTT endothelial cell viability and proliferation assay 
Cell proliferation was assessed by a colorimetric assay using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyl tetrazolium bromide (MTT, CT02 MTT Cell Growth Assay Kit, EMD Millipore, 
Darmstadt, Germany). Cells were cultured for 1hr, 4hrs, 24hrs and 5 days at an initial seeding 
density of 2×105 cells/ml on micropatterned thin film nitinol and the control sample with three 
replicates of each sample. After the determined incubation time, 0.01ml pre-warmed MTT 
solution was added to each culture well containing 0.1ml fresh cell medium and the cell culture 
plate containing MTT solution continued incubation for 4hrs under the same conditions. MTT 
solution has a pale yellow color which live cells cleave it to yield a dark blue formazan product. 
This transformation is catalyzed just by active cell mitochondria. Thus, the measurement of 
produced formazan can be an index of number of live cells. After 4hrs incubation of cells with 
MTT, 0.1ml isopropanol with 0.04 N HCl was added to each well. The HCl converts the phenol 
red in tissue culture medium to a yellow color that does not interfere with MTT formazan 
measurement. The isopropanol dissolves the formazan to give a homogeneous blue solution 
suitable for absorbance measurement. The absorbance was measured at a wavelength of 570nm 
using microplate reader (BioTek® Synergy 2, VT, USA).  
6.2.3.4 Morphology and coverage percentage of endothelial cells 
The morphology of endothelial cells adhered on substrates was probed by SEM after a thin layer 
of palladium (Pd) deposition by sputtering. For the SEM, cells were fixed with 2.5% 
glutaraldehyde (Sigma-Aldrich, MO, USA), dehydrated in a series of ethanol/DI water mixtures 
including 30%, 50%, 75%, 90% and 100% ratios, then, subjected to drying with 
hexamethyldisilazane (HMDS) (Alfa Aesar, MA, USA)/ethanol in 3:1, 1:1 and 1:3 volume 
ratios. The samples were dried in the hood overnight at room temperature. Coverage percentage 
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of endothelial cells on the micropatterned thin film nitinol and the control sample were analyzed 
using SEM images and MATLAB R2015a (MathWorks, MA, USA) image analysis. Five 
samples of the micropatterned thin film nitinol and control samples were used and in each 
sample four spots were randomly picked and used for the analysis (i.e., totally 20 images).  
6.2.4  Statistical analysis 
Values regarding to embolic microspheres capture efficiency of micropatterned thin film nitinol, 
optical density regarding to the MTT assay, aspect ratio of attached endothelial cells and 
endothelial cell coverage percentage were expressed as the mean value ± standard deviation 
(SD). Statistical analysis was performed for the experiment using one-way analysis of variance 
(ANOVA) test and Tukey’s HSD test by Minitab® 16.1.0 (©2010 Minitab Inc. PA, USA) and P-
value<0.01 was considered statistically significant.  
6.3  RESULTS 
6.3.1 Morphology and porosity percentage of micropatterned TFN samples 
Figure 52 shows the SEM images of micropatterned thin film nitinol samples. Multiple 
micropatterning morphologies (e.g., ellipse, diamond or circle) and dimensions with a uniform 
distribution and smooth edge patterns and a wide range of porosity percentage (i.e., 44%, 37%, 
32%, 17% and 15%) have been obtained.  
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Figure 52: SEM images of micropatterned TFN samples with porosity percentage and dimensions of micropatterns 
(dimensions: major axis×minor axis) 
 
 
 
6.3.2 The efficiency of micropatterned thin film nitinol samples to collect embolic 
particles 
Figure 53 shows the capture efficiency (i.e., ratio of the particle numbers kept by the thin film 
compared to the total particles) of micropatterned thin film nitinol samples. The lowest capture 
efficiency is 76.9±1.7 % which is observed in sample regarding to Figure 53A with 44% porosity 
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(i.e., the highest porosity) while the highest capture efficiency is 96.1±0.81 % in the 
micropatterned film with 15% porosity (i.e., the lowest porosity). It indicates that the porous 
TFNs effectively improve the embolism migration. By decreasing the flow rate and volume flow 
rate (VFR), the capture efficiency increases. In other words, in 65bpm flow rate, the level of 
embolism migration decreases in all the micropatterned stent grafts. By decreasing the particles 
mass, the capture efficiency slightly increases. It indicates that in lower accumulated deposition 
of plaques and fatty materials, the efficiency of these porous stent grafts increases. The capture 
efficiency of these micropatterned TFNs is pretty high for larger pieces of embolisms (e.g., 
>180µm). 
 
 
 
 
 
 
Figure 53: Capture efficiency percentage of micropatterned thin film nitinol samples 
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6.3.3  MTT cell viability and proliferation assay 
Figure 54 shows the mean value of endothelial cells viability on thin film nitinol and 
micropatterned thin film nitinol samples that were evaluated using the MTT assay over five 
different time periods (1hr, 2hrs, 4hrs, 1day and 5 days). After 1hr, 2hrs, 4hrs and 1 day, no 
significant difference is observed between the TFN and micropatterned TFN samples but after 5 
days, the optical density increases on the micropatterned TFN sample indicating the higher 
endothelial cell proliferation after micropatterning of the surface (P-value<0.01). 
 
 
 
 
 
 
Figure 54: MTT assay for endothelial cell viability cultured on the TFN and micropatterned TFN substrates after 
1hr, 2hrs, 4hrs, 24hrs and 5days 
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6.3.4  Quantification of endothelial cell elongation and alignment 
Figure 55 shows the representative fluorescent images of stained endothelial cells cultured on 
thin film nitinol and micropatterned thin film nitinol.  
 
 
 
 
 
 
Figure 55: Representative fluorescent images of F-actin stained endothelial cell cultured on A) Thin film nitinol, B) 
Micropatterned thin film nitinol after 48hrs 
 
 
 
The results of measuring the aspect ratio (i.e., ratio of the minor axis to the major axis) of 
endothelial cells cultured on the micropatterned TFN and TFN are shown in Figure 56. The 
aspect ratio indicated the level of elongation of cells such that lower amount of it indicates that 
cells are more elongated. The value of aspect ratio demonstrated that the elongation of cells is 
two times higher on the micropatterned surface of thin film nitinol.  
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Figure 56: Aspect ratio of endothelial cells cultured on micropatterned TFN and TFN after 48hrs 
 
 
 
Figure 57 shows the distribution of alignment angles of endothelial cells along the major 
axis of micropatterns of thin film nitinol. Quantitative analysis of actin alignment of endothelial 
cells on the micropatterns of TFN shows that around 35% of cells elongates along the major axis 
of the micropatterns with the angle of 40-50° and nearly 17% of cells elongate with 20-30° and 
17% with 50-60° and the rest of cells elongate with alignment angles of 0-20°, 30-40° and 60-
90° with approximately equal ratios. These results suggest that micropatterning impact the 
elongation and alignment of cells. 
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Figure 57: Alignment angles of endothelial cells along the major axis of micropatterns after 48hrs culture 
 
 
 
6.3.5 Morphology and coverage percentage of endothelial cells 
Figure 58 shows the representative SEM images of endothelial cells cultured on TFN and 
micropatterned TFN. Endothelial cells have spread out on the TFN substrate and major podia 
have emerged on the surface of cells (Figure 58A and C). Endothelial cells have spread out on 
the surface of micropatterned TFN and also grow on the porosities covering the total surface 
(Figure 58B, D and E). The endothelial cells integrate with each other on the micropatterned 
surface and show an integrated coverage on the surface.  
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Figure 58: Representative SEM images of endothelial cells cultured on A) TFN and B) micropatterned TFN, C) 
TFN in high magnification, D) Front face of micropatterned TFN in high magnification and E) Back face of 
micropatterned TFN in high magnification 
 
 
 
Quantitative analysis of SEM imaging shows that the coverage of endothelial cells are 
more than two times higher on the micropatterned TFN surface compared to the TFN surface 
(Figure 59). The coverage of endothelial cells on the front and back of micropatterned thin film 
nitinol is nearly the same level indicating the covering of the porosities and migration of 
endothelial cells. 
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Figure 59: Percentage of endothelial cell coverage on front and back faces of micropatterned TFN and TFN 
6.4 DISCUSSION 
In the native tissues, cells are surrounded with a 3D microenvironment consisting of extracellular 
matrix and neighboring cells which impose geometrical and topographical constraints. These 
conditions influence ECM ligands binding with the cell surface receptors affecting intracellular 
signaling pathways and impacting the cytoskeleton architecture e.g., actin network, cell polarity, 
migration, differentiation and growth. However, in the smooth surface of a biomaterial substrate 
(e.g., TFN), cells encounter a homogenous substrate which does not have many important 
features of the native tissue microenvironment; therefore, the micropatterning of biomaterials 
surface is an efficient method to create a microenvironment for cells that is closer to the in vivo 
condition and control the cellular responses in the microscale level to guide cells constructing a 
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tissue with properties similar to the native tissue. The morphology and alignment of cells in 3D 
cellular organization in a tissue impact the function of tissue for instance the alignment of muscle 
cells in the heart tissue is the crucial requirement for generating strong contractile force of the 
heart.  
Micropatterning of the surface allows manipulating the shape, porosity and dimension of 
microscale patterns and creating microenvironment to regulate multiple cellular responses. 
Several methods of patterning have been explored, including the creation of microgrooves and 
micropores[153, 154]. Micropatterning of medical stents has demonstrated the ability to regulate 
cell adhesion, proliferation, and differentiation along their surfaces by increasing the surface area 
of the stent exposed to the cells[155]. In order to reduce the risk of in-stent restenosis and 
thrombosis, it is crucial to prevent the proliferation and migration of smooth muscles cells while 
promoting rapid endothelialization[154]. Previous research has shown that micropatterning 
nitinol stents increases endothelialization along its surface[154]. 
In this study, the endothelial cell growth and elongation enhances upon micropatterning 
the surface of thin film of nitinol. Micropatterned TFN with 32% percentage porosity allows the 
blood perfusion to side microvessels and also demonstrates almost 90% efficacy to prevent the 
migration of embolic materials. During the deployment of stent, the superelastic thin film nitinol 
expands over the stent and the embolic materials place between the blood vessel wall and the 
thin film nitinol.  
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6.5 SUMMARY AND CONCLUSION 
Stroke and carotid artery atherosclerotic disease represents a significant disease burden in the 
United States, showing the third most common cause of mortality. Recently, endovascular 
treatment became more popular due to its less invasive and more cost-effective nature compared 
with the open surgery. The endovascular approach uses balloon angioplasty and placement of 
stents with the separate embolic protection filter devices, where the filter is not so effective in 
reducing periprocedural complications. Therefore, we introduced a new device that does not 
require embolic protection filter devices, as well as it is low-profile, thromboresistant, and 
versatile to fabricate various fenestrations. The micropatterned thin film nitinol in multiple 
geometries (i.e., diamond, oval and circle), various dimensions and porosities (i.e., 15-47%) was 
produced by sputter deposition and a subsequent lift-off method, and then covered on the 
backbone. The efficacy of various micropatterned thin film nitinol to capture the embolic 
particles was evaluated in various atherosclerotic carotid artery stenosis conditions through in 
vitro tests. The results demonstrated that the micropatterned thin film nitinol covered stent can 
prevent the emboli dislodgement up to 70-96% during 30min duration tests, suggesting a high 
potential for the carotid artery occlusive disease treatment. Besides, results of in vitro cell culture 
show that endothelial cell adhesion, growth and elongation significantly enhance on the 
diamond-shape micropatterned thin film nitinol (i.e., dimensions of 145µm×20µm and porosity 
percentage of 32%). Micropatterned thin film nitinol covered stent represents a high-potential 
low-profile device for treating carotid artery stenosis. In vivo studies must be carried on to 
demonstrate whether these preliminary results might translate into relevant clinical benefits as 
compared to the current available technologies.  
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7.0  CONCLUSION 
Population aging, obesity and inactive lifestyle lead to increasing demands for artificial medical 
devices (e.g., orthopedic and cardiovascular devices). In addition to increasing the demands, due 
to increasing the average life expectancy, the development of novel implantable devices with 
higher durability and functionality are urgently required. One of the keys to achieve this goal is 
to manage the interface between the implant and the host tissue via modifying the surface 
characteristics to increase the surface bio-functionality. Since 70–80% of implants are made of 
metallic biomaterials, developing surface modification techniques specific to metallic materials 
to enhance their biocompatibility is a pressing need in biomaterials field. In this study, four 
different novel surface treatment strategies are introduced for thin film nitinol and 316L stainless 
steel substrates for cardiovascular and orthopedic applications. For each strategy a target disease 
has been considered and the strategy and its efficacy in treating the disease has been explained:  
1. Grain size refinement of 316L stainless steel obtained by two-dimensional linear
plane-strain machining: 316L austenitic stainless steel samples with nanoscale grains were 
prepared under severe plastic deformation using linear plane-strain machining technique for 
three different rake angles (i.e., 0°, 20° and 40°). The average grain size of 316L stainless steel is 
about 22µm while after plane-strain machining, it reduces to nanometer scale (e.g., 42nm in 0° 
rake angle). Refining the grain size along with growing the oxide layer create surfaces with a 
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wide variety of surface topography, roughness and chemistry. The results of MC3T3 cell culture 
showed greatly improved cell adhesion and growth in nanoscale grain sample obtained by 0° 
rake angle. The oxide layer that is naturally formed on the surface demonstrated higher 
biocompatibility compared to both thermally and chemically formed oxides. 
2. Rapid electrostatic seeding of endothelial cells for thin film nitinol based 
endovascular grafts: Surface oxide layer (i.e., insulating layer) was grown on a 6µm thick thin 
film nitinol. Surface-treated thin film nitinol was used as the substrate for the electrostatic 
endothelial cell seeding. The induced electrostatic charge on the substrate was controlled through 
changing the applied voltages and it was calculated using Gauess’ law assuming the cylindrical 
capacitor model. This novel technique enables the thin film nitinol graft to endothelialize rapidly 
within the intravascular catheter such that the condition of 5V voltage with induced electrostatic 
charge of 0.68×10-6µC and induced electric field of 5.11V/mm-1 demonstrated to enhance the 
endothelial cell attachment on the thin film nitinol deployed inside the catheter. This study 
demonstrated that a novel metallic scaffold, thin film nitinol, could rapidly increase the number 
of cells attached on the surface via electrostatic cell seeding.   
3. Coating the thin film nitinol surface with electrospun silk: A thin layer of nanofiber 
silk was directly deposited onto the sputter-deposited thin film nitinol using electrospinning 
technique. While TFN is ultra-low profile (i.e., a few micrometers thick), relatively 
thromboresistant, and superelastic, its surface endothelialization is not rapid and sufficient. The 
electrospun silk layer showed significantly decreased thrombus and improved endothelialization 
compared to two conventional vascular grafts (i.e., Dacron® and e-PTFE). Therefore, integrated 
thin film nitinol/silk endograft represents a high-potential low-profile endovascular device, 
exploiting advantages from both thin film nitinol and thin electrospun silk layer.  
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4. Micropatterned thin film nitinol covered carotid artery embolic protection stent: 
Micropatterning process in multiple geometries (i.e., diamond, oval and circle), various 
dimensions and porosities (i.e., 15-47%) was performed on thin film nitinol substrate using 
sputter deposition and a subsequent lift-off method. The effectiveness of micropatterned TFNs 
covered stents in preventing the dislodgment and migration of plaque materials in atherosclerosis 
disease were tested using an in vitro set-up consisting of fluorescent microparticles as embolic 
particles. The results demonstrated that the micropatterned TFNs showed efficacy up to 70-96% 
in capturing the embolic particles during 30min duration tests. In addition, surface 
endothelialization drastically enhanced on the micropatterned TFN (i.e., diamond shape patterns 
with 145µm×20µm dimensions). Micropatterned TFN covered stent represents a high potential 
novel candidate device for carotid artery embolic protection device  
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